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ABSTRACT
AUTISM SPECTRUM DISORDER SYMPTOMATOLOGY IN CHILDREN WITH
NEUROFIBROMATOSIS TYPE 1
by
Christina L. Casnar

The University of Wisconsin – Milwaukee, 2017
Under the Supervision of Professor Bonita P. Klein-Tasman

Social problems are a common concern of parents of children with Neurofibromatosis
type 1 (NF1). There has been a recent surge of research examining the prevalence of autism
spectrum disorders (ASD) and ASD symptomatology in children with NF1. Findings from this
relatively new body of research are mixed. The primary aim of this study was to examine ASD
symptomatology in children with NF1 using a comprehensive assessment of ASD symptoms. A
second aim was to examine possible variables that may contribute to socio-communicative
difficulties. Participants included 25 children with NF1 between the ages of 9 and 13, along with
their parent. Standardized parent-report questionnaires were used to assess social responsiveness
and restrictive and repetitive behaviors (RRB; Social Responsiveness Scale, Second Edition:
SRS-2) and ASD symptomatology (Social Communication Questionnaire: SCQ). Diagnostic
assessment measures for ASD were used to examine the frequency and severity of ASD
symptomatology (Autism Screening Interview: ASI, and Autism Diagnostic Observation Scale,
Second Edition: ADOS-2). Selected measures were used to assess intellectual functioning,
attention, social cognition, and pragmatic language. Overall, results indicate that 30% of parents
observed mild to moderate social responsiveness difficulties and RRB on the SRS-2. However,
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no children met diagnostic criteria for ASD based on the combination of ASI and ADOS-2
classifications and very few RRB were reported by parents or observed by clinicians. Relations
between social responsiveness and intellectual functioning, social information processing, and
pragmatic language were found. Performance on a pragmatic language task uniquely explained
38% of the social responsiveness difficulties reported by parents. Results indicate that children
with NF1 are demonstrating elevated ASD symptomatology per parent and clinician report;
however, those difficulties are largely not severe nor pervasive enough to meet criteria for ASD.
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Autism Spectrum Disorder Symptomatology in Children
with Neurofibromatosis Type 1
Neurofibromatosis type 1 (NF1) is one of the most common genetic disorders, presenting
in approximately 1 in 3,500 live births. NF1 is a highly variable condition with a large number of
medical, cognitive, and psychosocial sequelae. During childhood, medical features of the disease
most often include the presence of café-au-lait spots and skinfold freckling. However, the most
common manifestations reported by parents of children with NF1 are difficulties in cognition
and psychosocial functioning. Previous research has focused on exploring the
neuropsychological phenotype of children with NF1 and examining broad domains of
psychosocial functioning. A growing body of literature has recently begun to examine the social
functioning of children with NF1, and more specifically, exploring possible variables that may
contribute to poor social functioning. Additionally, there has been a recent surge of research
examining the prevalence of autism spectrum disorders (ASD) in children with NF1. Findings
from this relatively new body of research are mixed, with some studies reporting high rates of
ASD and ASD symptomatology in children with NF1 and some studies reporting only mild
social difficulties. Therefore, the primary aim of this study was to examine ASD
symptomatology in children with NF1 using a comprehensive assessment of ASD symptoms. In
addition, this study aimed to examine possible variables that may contribute to sociocommunicative difficulties, such as intellectual functioning, attention, social cognition, and
pragmatic language skills.
In this introduction, the current literature on the social difficulties and ASD
symptomatology often reported in children with NF1 will be examined. First, I will provide
general background information about NF1. I will briefly describe medical features and the
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common cognitive and behavioral characteristics of individuals with NF1. Second, I will review
research examining social difficulties and risk factors that may contribute to poor social
outcomes in children with NF1. Third, I will provide general background information about
ASD. I will briefly describe the diagnostic criteria and symptoms associated with ASD. Fourth,
current research examining the overlap between NF1 social difficulties and ASD
symptomatology will be explored. Finally, I will provide a brief summary and rationale for the
current study.
Literature Review
Neurofibromatosis Type 1
Neurofibromatosis type 1 is an autosomal dominant disorder with an incidence of
approximately 1 in 3,500 live births (Huson & Hughes, 1994; North, Riccardi, SamangoSprouse, & Ferner, 1997). NF1 is caused by a mutation of the NF1 gene on the long arm of
chromosome 17q11.2, which is responsible for encoding neurofibromin. NF1 has an autosomal
dominant pattern of inheritance, although half of all cases result from a spontaneous mutation.
Diagnosis requires the presence of two or more of the following criteria: (1) 6 or more café au
lait spots, (2) axillary or inguinal freckling, (3) 2 or more cutaneous neurofibromas, (4) 1
pexiform neurofibroma, (5) 2 or more iris Lisch nodules, (6) an optic glioma, (7) a characteristic
body lesion, or (8) first degree relative with NF1 (NIH Consensus Development Conference,
1987). The most common manifestations to first appear in childhood are café au lait spots and
axillary freckling. A study of children with NF1 by Cnossen et al. (1998) reported that as many
as 96.7% of children diagnosed with NF1 displayed six or more café au lait spots by 3 years of
age. Freckling was found in 85.3% of children with NF1 by the 4 years of age (Cnossen et al.,
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1998). Recent advances in genetic testing have made it possible to confirm diagnosis in
approximately 95% of individuals diagnosed clinically with NF1 (Tonsgard, 2006).
Neuropsychological Phenotype of Children with NF1
NF1 is a highly variable condition with a large number of medical, cognitive, and
psychosocial difficulties and while physical medical features are indeed problematic for many
children with NF1, the most common complaints from parents of children with NF1 are not
medical in nature, but rather neuropsychological and behavioral. Children with NF1 are at higher
risk for cognitive problems, as well as learning and attention difficulties. Several studies have
found that although children with NF1 have cognitive abilities that fall in the average range, the
IQ curve is shifted to the left (with a mean around 90) when compared to unaffected children
(Hyman, Shores, & North, 2005; North, Joy, Yuille, Cocks, & Hutchins; 1995). Additionally, it
has been suggested that as many as 50-65% of children with NF1 have a learning disability, with
variability in the nature of the learning disability (Brewer, Moore, & Hiscock, 1997; Hyman et
al., 2005; Krab et al., 2008; North et al., 1995). Based on current literature, up to half of children
with NF1 have visuospatial ability difficulties, with performance falling one standard deviation
or more below population norms even after controlling for intellectual functioning and attention
difficulties (Hyman et al., 2005; Levine, Materek, Abel, O’Donnell, & Cutting, 2006;
Schrimsher, 2003). Fine motor coordination impairment and low motor speed have been reported
in 20-30% of children with NF1 (Casnar, Janke, van der Fluit, Brei, & Klein-Tasman, 2014;
Hyman et al., 2005; Levine et al., 2006). Executive functioning and attention skills have also
been shown to be an area of difficulty for children with NF1 (Casnar & Klein-Tasman, 2016;
Hyman et al., 2005; Ferner, Chaudhuri, Bingham, Cox, & Hughes, 1993; Huijbregts, Swaab, &
de Sonneville, 2010; Payne, Hyman, Shores, & North, 2011; Pride, Payne, & North, 2012;
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Rowbotham, Pit-ten Cate, Sonuga-Barke, & Huijbregts, 2009). Hachon, Iannuzzi, and Chaix
(2011) report that 30-50% of children with NF1 meet the diagnostic criteria for ADHD. Finally,
in regards to psychosocial functioning, research suggests that children with NF1 have more
difficulties than unaffected children on measures of internalizing and externalizing disorders
(Barton & North, 2004; Graf, Landolt, Mori, & Boltshauser, 2006; Johnson, Saal, Lovell, &
Schorry, 1999; Noll et al., 2007).
Social Functioning in Children with NF1
Early studies examining parental report of general psychosocial functioning found that
children with NF1 are frequently teased, more often rejected by their peers, have difficulties
forming friendships, and have more difficulty getting along with siblings than typically
developing children (Benjamin et al., 1993; Dilts, Carey, Kircher, & Hoffman, 1996; Johnson et
al., 1999; North et al., 1995). Barton and North (2004) examined parent, teacher, and self-report
of social skills in children with NF1 compared to unaffected siblings. No significant differences
between groups were found; however, children with NF1 had poorer social skills compared to
normative data. Noll et al. (2007) investigated social behavior and peer relationships in children
with NF1 using classroom peer and teacher ratings. Results indicated that children with NF1 had
fewer friendships, were selected less often as a best friend, and were less well liked than their
classroom peers. Their teachers and peers also rated them as having fewer leadership skills and
being more sensitive and isolated. However, it is important to note that teachers reported more
prosocial behaviors in children with NF1 relative to their peers.
The reasons for poor social functioning in children with NF1 are not well understood.
Several researchers have examined possible risk factors for poor social skills and social outcome
in NF1 (Barton & North, 2004; Eeghen, Ueland, & Johansen, 2012; Huijbregts et al., 2010;
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Huijbregts & Sonneville, 2011; Noll et al., 2007). Barton and North (2004) attempted to parse
out possible factors that could contribute to poor social functioning, such as, intellectual
functioning, learning disabilities, low academic achievement, ADHD, physical symptoms
associated with NF1, and pattern of inheritance. Barton and North (2004) reported finding no
significant relations between the risk factors examined, with the exception of ADHD. These
authors found that children with comorbid NF1 and ADHD had poorer social skills than any
other subgroups examined (NF-Alone, NF-Low Academic/LD). Walsh et al. (2013) found
similar significant relations between ADHD symptoms, social information processing, and social
communication in their study. Additionally, Noll et al. (2007) also examined the relation
between social problems and neurological involvement (which included conditions such as
ADHD, LD, Borderline IQ, seizures, etc.) in their peer and teacher rating study and found
neurological severity to be significantly related to social problems. These finding suggest that
attention difficulties and learning problems, which are found in higher frequency in the NF1
population, may be affecting children with NF1’s ability to facilitate positive social interactions
and foster successful peer relationships.
Few studies have explored how social information processing skills may relate to social
difficulties. Huijbregts et al. (2010) examined the relation between social information processing
and cognitive control in 32 children with NF1 compared to 32 unaffected children. Children with
NF1 had difficulties identifying fear and anger. They also had more difficulty on profile facial
recognition and matching facial emotions. Results also indicated that while cognitive control
played a large role in impaired facial processing, children with NF1 still had difficulty with
bottom-up encoding of social stimuli. Additionally, Huijbregts et al. (2010) found that many of
the significant group differences remained after excluding children with a known diagnosis of
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ADHD from the analysis. The authors suggest that these findings may indicate that attention
deficits do not determine social information processing difficulties in NF1 and that despite a
well-documented association between ADHD and cognitive control deficits, there appears to be
NF1-specific neuronal abnormalities that causes problems with cognitive control and social
processing. Huijbregts and Sonneville (2011) found similar results when investigating relations
between cognitive ability (including processing speed and cognitive control), social information
processing, and socio-emotional problems in 30 children with NF1 compared to 30 healthy
control children. Children with NF1 had poorer cognitive control, slower processing speed, and
lower social information processing scores compared to healthy controls. For children with NF1,
cognitive abilities best explained variability in emotional problems and social responsiveness,
whereas social information processing deficits best explained variability in conduct and peer
relations problems. However, group differences in autistic traits, peer problems, social skills, and
hyperactivity-inattention symptoms remained even after controlling for cognitive ability and
social processing. This suggests that children with NF1 are demonstrating difficulties with both
top-down processing (cognitive control) and bottom-up (social information processing) of social
information.
In sum, these studies seem to suggest that the social difficulties described by parents and
teachers of children with NF1 may at least be in part due to certain risk factors or aspects of
cognitive processing. Attention difficulties, intellectual ability, learning disorders, and social
cognition skills all appear to explain away some of the social difficulties reported by parents and
teachers, yet social difficulties consistently remain. However, findings from these studies should
be interpreted with caution. Many studies utilized a small sample size that stretched across a
broad age range. Small sample sizes could limit the power necessary to detect moderating
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factors. Additionally, many studies relied on medical record review in determining diagnosis of
ADHD, LD and other variables. Although medical records often include formal
neuropsychological testing, assessment procedures are often quite varied and could have been
completed at different ages. A more uniform, systematic assessment of risk factors is needed.
Finally, from a more theoretical standpoint, since successful social functioning requires the
collaboration of many distinct, but related, cognitive processes, it is difficult to tease apart what
exact processing skills are responsible for which exact deficit. However, what is clear from the
research described above is that parents and teachers are concerned about the social functioning
of children with NF1 and more research is needed to identify the social behaviors that are most
problematic and the associated risk factors that may play an important role in those difficulties.
Autism Spectrum Disorders
Autism Spectrum Disorder is a developmental disorder characterized by significant and
persistent impairments in social communication, social interaction, and restricted and repetitive
patterns of behavior or interests. Current general population prevalence rates for ASD are
estimated to be 1:68 children, with males showing a greater incidence (1:42) than females
(1:189; Centers for Disease Control and Prevention [CDC], 2014). Symptoms are evident in
early childhood and core symptoms are suggested to be apparent by 12 months of age (Maestro
et al., 2002; Werner, Dawson, Osterling, & Dinno, 2000; Werner & Dawson, 2005). Most
researchers agree that ASD is a complex disorder in which both environmental and genetic
factors play a role in who develops the disorder (Mazina et al., 2015). Evidence from twin and
sibling studies provides strong support for the involvement of genetic risk factors in the
development of ASD (Bailey et al., 1995; Folstein & Rutter, 1977; Smalley, Asarno, & Spence,
1988). Many genome-wide linkage studies of ASD have been conducted in order to explore
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possible genetic underpinnings; however, results from these studies have shown limited success
(Yuen et al., 2015). Several single-gene disorders have been associated with an increased risk for
ASD or expression of ASD symptomatology, including fragile X syndrome, Rett syndrome,
tuberous sclerosis, and NF1 (CDC, 2014). Research examining ASD symptomatology in these
single-gene disorders provides a platform for future research aimed at characterizing the possible
genetic risk factors and cognitive mechanisms for the development of ASD.
DSM-5 diagnosis of ASD requires the presence of deficits in two core domains. The first
domain includes deficits in social communication and social interaction (SCI) that must be
present across multiple contexts. Symptoms described in this domain include (1) deficits in
social-emotional reciprocity; (2) deficits in nonverbal communicative behaviors used for social
interaction; and (3) deficits in developing, maintaining, or understanding social relationships.
The second domain includes the presence of restricted repetitive patterns of behavior, interest, or
activities (RRB). Symptoms described in this domain include (1) stereotyped or repetitive motor
movements, use of objects, or activities; (2) insistence on sameness, inflexibility to routines, or
ritualized patterns of verbal or nonverbal behavior; (3) highly restricted, fixated interest that are
abnormal for developmental level; and (4) hyper- or hypo-activity to sensory import or unusual
interested in sensory aspects. At least two symptoms must be present in this domain in order to
meet diagnostic criteria for ASD. Additionally, the criteria specify that symptoms must be
present in early development, cause clinically significant impairment, and are not better
explained by an intellectual disability or global developmental delay (American Psychiatric
Association, 2013). The DSM-5 diagnostic criteria also include a severity specifier that was
intended to help clinicians succinctly describe the current symptomatology.
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Diagnostic procedures for ASD are often quite varied depending on provider preferences
and provider resources. Typically, an ASD diagnosis is made by a clinical psychologist,
psychiatrist, or neurologist and includes an interview with a caregiver regarding early
development and ASD symptomatology, behavioral observations made by the clinician, and
formal assessment. It is important to note that the diagnosis of ASD in individuals with a genetic
condition can be especially challenging. Many genetic syndromes present with sociocommunicate difficulties that overlap with ASD symptoms; however, the presence of these
behaviors themselves does not necessary warrant a comorbid ASD diagnosis. The complex, and
often unusual, cognitive and behavioral phenotypes that are characteristic of numerous genetic
disorders may result in individuals reaching and/or exceeding ADI-R and ADOS-2 cutoffs
artificially (Moss & Howlin, 2009). This could be especially true if the genetic syndrome is
associated with intellectual disability (Kaufman, Ayub, & Vincent, 2010). Therefore, it is
important to disentangle the association between ASD and genetic symptomatology meticulously
at both the diagnostic and behavioral level.
Much of the previous research examining ASD symptomatology in children with NF1
utilized DSM-IV diagnostic criteria and/or ASD diagnostic classifications based on an algorithm
which was developed by the National Institute of Child Health and Human Development
Collaborative Programs of Excellence in Autism (CPEA; Lainhart et al., 2006). The DSM-5
criteria for ASD are thought to be stricter and more thorough compared to the DSM-IV criteria
and CPEA guidelines (Grzadzinski, Dick, Lord, & Bishop, 2016; Lainhart et al., 2006; Young &
Rodi 2014). The DSM-IV identified a set of Pervasive Developmental Disorders that were
considered to fall under the ASD umbrella, including Autistic Disorder, Asperger's Disorder, and
Pervasive Developmental Disorder Not Otherwise Specified (PDD-NOS). Besides the removal
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of Asperger's Disorder and PDD-NOS as separate disorders, the new DSM-5 criteria made
significant changes to the specific criteria needed for a diagnosis of ASD. For example, in the
DSM-5 criteria, evidence of impairment needs to be present for all three symptoms listed in the
SCI domain and at least 2 of the 4 symptoms listed in the RRB domain. The old DSM-IV criteria
required the presence of a total of six (or more) symptoms from the Social Interaction (SI),
Social Communication (SC), and RRB domains, with at least two from the SI, one from the SC,
and one from the RRB domains. Therefore, a child only needed to show evidence of one RRB, as
opposed to the two that are required for a diagnosis of Autism from the DSM-5. Furthermore, an
individual could be diagnosed with PDD-NOS based on a range of symptomatology that might
or might not include RRBs.
CPEA diagnostic guidelines for Autism, Asperger’s Disorder, and broad-ASD were
developed for research purposes to ensure standardized diagnostic classifications across research
sites and are based upon scores from the ADI-R, ADOS, and Best Estimate Clinical (BEC)
diagnosis as determined by a clinician (CPEA; Lainhart et al., 2006). According to CPEA
guidelines, for a diagnosis of Autism or Asperger’s Disorder an individual must meet specific
ADI-R classification cutoffs, ADOS classification of “Autism” or Autism Spectrum”, and/or
BEC, which is similar to the diagnostic criteria in the DSM-5. However, the classification
criteria threshold for broad-ASD is not restricted to DSM-5 diagnostic criteria. Additionally, the
CPEA approach relaxed the empirically-developed diagnostic algorithms for the ADI-R and
ADOS. In order to meet for a diagnosis for broad-ASD an individual only needs to meet ADI-R
cutoffs in 1 in the following 3 ways: 1) Meet cutoffs on the SI and SC domains, 2) Meet cutoffs
on either the SI or SC domains and score with 2 points of the cutoff of the other, or 3) Score
within 1 point of both the SI and SC domains (see Appendix A for a complete explanation of
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CPEA diagnostic criteria). None of these methods requires the presence of RRB symptoms. This
means that no RRB would need to be evident in order to meet diagnostic criteria for broad-ASD,
which is in stark contrast to the diagnostic criteria presented in DSM-5. Additionally,
subthreshold scores on the SI and SC domains would also suffice for a diagnosis of ASD
according to CPEA guidelines.
Autism Spectrum Disorder Symptoms in Children with NF1
Recently, there has been a surge of research examining prevalence rates of ASD within
the NF1 population. As described above, it has been well established that children with NF1
show impairments in social functioning per parent and teacher report (Benjamin et al., 1993;
Dilts, Carey, Kircher, & Hoffman, 1996; Huijbregts et al., 2010; Huijbregts and Sonneville,
2011; Johnson et al., 1999; North et al., 1995). Additionally, early ASD prevalence studies and
case studies indicated an increased rate of NF1 in the ASD population. These early studies found
relatively low to moderate levels of co-occurrence, ranging from 0.6 to 6% (Fombonne, Du
Mazaubrun, Cans, & Grandjean, 1997; Gillberg & Forsell, 1984; Mouridsen, Andersen,
Sorensen, Rich, & Isager, 1992; Williams & Hersh, 1998). These studies were the first to
demonstrate a relation between NF1 and ASD, but were limited by their variability in design and
potential sampling bias.
More recently, several studies have examined the relations between NF1 social
difficulties and ASD symptomatology more systematically. The majority of this research has
been done using social responsiveness and RRB screening measures, such as the Social
Responsiveness Scale (SRS; Constantino & Gruber, 2005) and the Children Social Behavior
Questionnaire (CSBQ; Luteijn, Jackson, Volkmar, & Minderaa, 1998), and/or by utilizing ASDspecific screening measures, such as the Social Communication Questionnaire (SCQ; Rutter,
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Bailey, & Lord, 2003), Modified Checklist of Autism for Toddlers (M-CHAT; Robins, Fein,
Barton, & Green, 2001) and the Childhood Asperger Syndrome Test (CAST; Scott, BaronCohen, Bolton, & Brayne, 2002). Currently, these studies report elevated levels of ASD
symptomatology in 11-29% of individuals with NF1 (Walsh et al., 2013; Garg et al., 2013a;
Garg et al., 2013b; Tinker et al., 2014; Adviento et al., 2013; Plasschaert et al., 2014).
Walsh et al. (2013) examined parental report of ASD symptomatology using the SRS in
66 school-aged children and found significantly elevated symptomatology. Walsh et al. (2013)
noted that 14% of the sample reached clinically significant levels (T-score <75) of ASD
symptomatology. The authors indicated that the most commonly reported ASD symptoms were
in the Autistic Mannerisms domain (elevated in 44% of the sample), which assesses RRB, such
as, problems with flexibility, transitions, and perseverative behaviors. Impairments on the Social
Communication, Motivation, Awareness, and Cognition domain scores were also present for
30% of the sample. Garg et al. (2013b) also used the SRS to assess ASD symptomatology in 109
school-aged children with NF1 and found that 29% of the children scored in the severe range and
26% scored in the mild to moderate range using the SRS Total Score by parent report. Sixtyeight percent of children in this study scored in the mild, moderate, or severe range by their
parents on the Autistic Mannerism domain. However, rates of difficulties were significantly
lower on a subset of children in which teacher report of SRS scores were available. According to
teacher report, only 6% of children scored in the severe clinical range and 25% scored in the
mild to moderate range on the SRS Total Score. Additionally, only 26% of children with NF1
were reported to have elevated scores (T-score >60) on the Autistic Mannerisms domain by their
teachers, suggesting that teachers are seeing fewer social responsiveness difficulties, RRB, and
less ASD symptomatology within the school setting.
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Tinker et al. (2014) examined ASD symptomatology in 40 school-aged children with
NF1 using the CAST, an autism specific screening questionnaire. Tinker et al. (2014) were
interested in examining prevalence rates using a comparison to general population norms
provided by Williams et al. (2005). Tinker et al (2014) reported that 5 out of 40, or 13%,
screened positive on the CAST, which was not significantly different from the Williams et al.
(2005) general population data (6%). However, the authors did note that children with NF1 had
higher mean and median scores when compared to control norms. The authors proposed that
results could suggest that school-aged children with NF1 may exhibit more ASD symptoms,
without actually meeting threshold for a true diagnosis of ASD. The authors examined the
questions that were most often endorsed and found that both social communication and RRB
were reported by parents.
Adviento et al. (2013) assessed ASD symptomatology using the SCQ and SRS in a
sample of 66 school-aged children and adults with NF1, along with a sample of children and
adults with other RASopathies (e.g. Noonan (NS), Costello (CS), and cardio-faco-cutaneous
(CFC) syndromes). On the SCQ, 11% of participants with NF1 had scores above the threshold
indicative of a possible ASD diagnosis. The NF1 group had the lowest reported rates of ASD
symptomatology on the SCQ within the sample of RASopathies, with 54% of CFC, 26% of CS,
and 21% of NS participants meeting or exceeding the threshold. On the SRS, mean scores for
participants with NF1 were within the normal range (M = 57, SD = 16) per parent report;
however, approximately 13% received scores in the severe clinical range and 30% received
scores in the mild to moderate range. This was, again, the lowest score compared to the other
RASopathies (CFC: M = 74, SD =13; NS: M = 65, SD = 17; CS: M = 61, SD = 10). Adviento et
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al. (2013) also indicated that 7 out of 66 (11%) NF1 participants exceeded cutoff on both the
SCQ and SRS.
Finally, a recent study by Plasschaert et al. (2014) examined ASD symptomatology using
the CSBQ and SRS in a sample of 82 school-aged children with NF1. The authors reported that
the mean total score for both the CSBQ and the SRS were significantly higher than the normative
mean (CSBQ: NF1 raw = 24.8, SD = 16.3; Normative raw = 10.2, SD = 9.0; SRS: NF1 M =
69.94, SD = 19.29). Thirty percent of children with NF1 scored in the mild to moderate range
and an additional 33% scored in the severe clinical range on the SRS Total Score. Plasschaert et
al. (2014) noted that the Social Cognition domain was the most severely affected (elevated in
66% of the sample), followed by subclinical elevations in the Social Communication (57%) and
Autistic Mannerisms (58%) domains. Age was significantly correlated to symptomatology, with
more social difficulties reported with increasing age. Plasschaert et al. (2014) found significantly
less social problem behaviors reported in children with NF1 before the age of 8. The authors also
noted that males were reported to have significantly more social problems than females on both
measures.
Only one study has examined ASD symptomatology in young children with NF1. Tinker
et al. (2014) examined parental report of ASD symptomatology using the M-CHAT on a sample
of toddlers with NF1. The M-CHAT is a widely used ASD screening measure and was
developed for children between the ages of 16 to 48 months. The M-CHAT utilizes a cutoff
score to specify a positive screen, which indicates a need for further evaluation. Tinker et al.
(2014) compared the M-CHAT scores to general population norms provided by Robins et al.
(2001) and Miller et al. (2011). Tinker et al. (2014) did not find an increased rate of ASD in their
sample of NF1 toddlers using the M-CHAT. In fact, 0 out of 20 toddlers with NF1 screened
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positive, compared to 5% from Robin et al. (2001) and 6% from the Miller et al. (2011) general
population studies. These findings are different from previous research examining ASD
symptomatology in school-aged children (Adviento et al., 2013; Garg et al., 2013b; Plasschaert
et al., 2014; Walsh et al., 2013), suggesting that young children with NF1 are not at a
significantly increased risk for ASD. The authors proposed a couple different ways of
interpreting the results of their study. One interpretation suggested that children with NF1 show
certain characteristics that put them at a higher risk for ASD symptoms, but they do not have an
increased risk for a diagnosis of ASD when compared to the general population. The authors also
proposed that it is possible that children with NF1 may not manifest ASD symptoms until later in
life (e.g. school-age); however, this would be in stark contrast to what is known regarding the
early development of socio-communicative difficulties and RRB in children with ASD (Maestro
et al., 2002; Werner, Dawson, Osterling & Dinno, 2000; Werner & Dawson, 2005). Finally,
Tinker et al. (2014) suggest that it may be that the M-CHAT is not a sensitive ASD screening
measure for children with NF1.
Studies examining the overlap between NF1 and ASD symptomatology using
questionnaire data are essential for better understanding parent and teacher perspectives of sociocommunicative difficulties in children with NF1. To date, several studies have specifically
examined this overlap and, unfortunately, the findings are still mixed. The studies described
above have several limitations that may make interpretation difficult and may contribute to the
variability in findings. Most studies reviewed used published, normative data as their comparison
control group. Doing this could mask subtle difficulties that may still be significant for children
with NF1. Also, when examining finding by their geographical location, it appears that European
studies (Garg et al., 2013b; Plasschaert et al., 2014) tend to report higher rates of severe
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difficulties compared to American studies (Walsh et al., 2013; Tinker et al., 2014; Adviento et
al., 2013). It is unclear whether there may be cultural factors at play that affect the type and/or
frequency of social difficulties and RRB that parents of children with NF1 are reporting.
Additionally, as Payne (2013) points out, it is important to keep in mind that while
questionnaires can provide us with useful information about symptoms, they do not indicate
disorder. While the SRS has demonstrated good psychometric properties, recent studies suggest
that elevated scores on the SRS are strongly correlated to problem behavior, more generally
(Charman et al., 2007; Hus, Bishop, Gotham, Huerta, & Lord, 2012). Therefore, it is possible
that there is an increased risk of false positives for children with NF1 given they often display a
wide-range of problem behaviors that overlap with other neurodevelopmental disorders, such as
attention difficulties and externalizing and internalizing problems.
ASD in NF1 using Comprehensive Evaluations
Only four studies have examined NF1 and ASD symptomatology using comprehensive
autism diagnostic evaluation. A follow-up, population-based prevalence study by Garg et al.
(2013a) investigated ASD diagnosis using the Autism Diagnostic Interview-Revised (ADI-R:
Lord, Rutter, & Le Couteur, 1994) and the Autism Diagnostic Observation Schedule-Generic
(ADOS-G: Lord et al., 2000) in a sample of children with NF1. The ADI-R is a standardized
parent interview used to help aide in the diagnosis of ASD. The ADOS-G is a semi-structured
observational assessment of socio-communication, social interaction, and play skills. It is
important to note that the ADOS-G diagnostic algorithm does not include assessment of RRB,
which has been identified as a core and necessary symptom cluster of ASD according to the
DSM-5 (American Psychiatric Association, 2013). ASD diagnostic classification was based on
CPEA diagnostic guidelines (CPEA; Lainhart et al., 2006). Participants included 47 children

16

from the Garg et al. (2013b) screening study. The authors indicated that 30% of children with
NF1 met criteria for ASD, 28% met criteria for broad ASD, and 43% were identified as nonspectrum. After adjusting for probability of responding rates from the first study (Garg et al,
2013b), whole-population prevalence in NF1 was identified as 25% for ASD and 21% for broad
ASD. The authors did not find a significant difference in intellectual functioning between the
three groups. Severity of everyday adaptive functioning, and severity of socialization and
communication impairment on the ADOS-G and ADI-R were ordered across the three groups as
would be expected, with most impairment in the ASD group. However, RRB (based on the ADIR) and deficits in everyday socialization skills (based on the Vineland Adaptive Behavior Scale)
were particularly associated with the ASD group. The authors collapsed the ASD and broad ASD
groups to compare with the non-spectrum children. Results indicated no significant differences
in age, SES, familial NF1 status, NF1 physical severity, or special educational services between
ASD children and non-spectrum children. Garg et al. (2013a) noted that there was a significantly
higher male to female ratio in the ASD group.
Adviento et al. (2013) also conducted a follow-up study that examined ASD symptoms in
three children with NF1 who screened positive for ASD (on at least one screening measure) in
their ASD screening study described above. The authors also evaluated one negative control
participant, with below-threshold scores on both screening measures. A comprehensive
assessment that examined intellectual functioning, adaptive functioning, and ASD symptoms
using the ADI-R and the Autism Diagnostic Observation Schedule, Second Edition (ADOS-2:
Lord, Rutter, Risi, Gotham, & Bishop, 2012) was conducted. Results were provided for each
participant. The negative control participant, who did not initially screen positive for ASD,
received a classification of non-spectrum on both the ADI-R and ADOS-2. Two of the 3 children
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who initially screened positive for ASD received classifications of autism or autism spectrum on
both the ADI-R and ADOS-2. The third child, who initially screened positive for ASD, received
a classification of non-spectrum on the ADI-R and ADOS-2 and was diagnosed with Social
Anxiety Disorder. Final determination of an ASD diagnosis was based on clinical impressions
and generally matched ADI-R and ADOS-2 classifications. The most frequent impairments on
the ADOS-2 across all the RASopathies were in speech abnormalities, limited inquiry into the
thoughts, feelings or experiences of others, and limited sharing of information about oneself,
poor recognition of others emotions, poor insight into typical social relationships, and deficits in
imaginative use of objects (Adviento et al., 2013).
Plasschaert et al. (2014) also conducted a follow-up study examining ASD symptoms in a
subset of children with NF1. Selection was based on results from screening measures and clinical
impression. ASD diagnosis was determined using DSM-IV-TR diagnostic criteria and made by a
multidisciplinary team of educational psychologists, a speech therapist, and a child psychiatrist.
Thirty-one children with NF1 underwent a comprehensive ASD evaluation that included
assessment of intellectual functioning and administration of the ADOS-2. Results indicated that
27 of the 33 children evaluated received an ASD diagnosis. When taking into consideration all of
the children screened in the initial study, Plasschaert et al. (2014) concluded that a minimum
prevalence estimate of 26% of ASD was found in NF1. No significant difference in the
proportion of familial versus sporadic cases of NF1 was found; however, a higher male to female
ratio was reported in the ASD group. The authors indicated that according to ADOS-2 analysis,
15% of the group presented with minimal ASD symptoms, 48% presented with moderate ASD
symptoms, and 4% presented with severe ASD symptoms. However, results of this study should
be interpreted with caution, as 14% of the children who were diagnosed with ASD did not have
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ADOS-2 scores available. Additionally, detailed information about ADOS-2 scores and how
clinical diagnosis was determined was not adequately described in the article.
Finally, Garg et al. (2015) examined ASD symptomatology in 36 children with a
comorbid diagnosis of NF1 and ASD (NF1+ASD). In this study, Garg et al. (2015) described the
behavioral phenotype of children with NF1 together with a diagnosis of ASD (based on meeting
or exceeding the cutoff scores on the SRS and ADOS-2 algorithm items). Results indicate that
generally, children with NF1+ASD demonstrated a similar behavioral phenotype to the
ASD/autism groups provided in the ADOS-2 manual (Lord et al., 2012). However, children with
NF1+ASD had better eye contact, fewer RRB, and better language skills compared to the
ASD/autism groups. Results also noted a discrepancy between parent-reported and clinicianobserved RRB symptoms, with 67% of parents reporting severe elevations in RRB on the SRS
and clinicians observing RRB in only a few children with NF1. The authors suggested that given
these findings, the new DSM-5 diagnosis of Social (Pragmatic) Communication Disorder (SCD)
may more accurately describe the social impairments seen in the NF1+ASD group (American
Psychiatric Association, 2013).
Overall, while these recent comprehensive studies are important for better understanding
the overlap of ASD and NF1, they are not without limitations. One limitation includes the
potential overestimation of prevalence rates due to response bias during both the screening stage
and during the comprehensive assessment stage. Additionally, few studies reported data
regarding specific ASD symptom frequency and severity. Having more information about the
most commonly reported symptoms and level of severity would be important clinical
information for parents and caregivers of children with NF1 and would also characterize the
nature of difficulties typically observed for those who exceed cutoff. Finally, some of the studies
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reviewed above relied on DSM-IV diagnostic criteria for ASD that did not require symptoms
from the RRB domain to be endorsed, which could lead to an overestimate of diagnoses.
Therefore, more research is needed to examine specific ASD behaviors, as well as the frequency
and severity of those behaviors, in children with NF1.
Summary and Study Rationale
Social problems are a common concern of parents of children with NF1 (Benjamin et al.,
1993; Dilts et al., 1996; Johnson et al., 1999; North et al., 1995). Data on parental report of social
difficulties indicate significant elevations in autistic traits, peer problems, and social skill
difficulties (Barton & North, 2004; Noll et al., 2007). While difficulties in intellectual
functioning, attention, learning problems, and social information processing can explain some of
the difficulties in social functioning, they do not explain all of the variance (Eeghen et al., 2012;
Huijbregts et al., 2010; Huijbregts & Sonneville, 2011). Studies investigating prevalence rates
and symptoms clusters of ASD in NF1 are inconsistent (Adviento et al., 2013; Garg et al., 2013b;
Garg et al., 2013a; Plasschaert et al., 2014; Tinker et al., 2014; Walsh et al., 2013). Therefore, a
systematic examination of specific ASD symptomatology and its relation to risk factors for
social difficulties is much needed. The study design was choosen to utilize both descriptive and
exploratatory methods in order to broaden and build upon existing literature. The primary aim of
the current study was to examine ASD symptomatology in children with NF1 using a
comprehensive assessment of ASD symptoms. In addition, this study aimed to examine possible
variables that may contribute to socio-communicative difficulties, such as intellectual
functioning, attention, social cognition, and pragmatic language skills.

20

Methods
Research Questions
Primary Aim: To explore socio-communicative behavior in children with NF1, and in
particular, to examine overlaps in symptoms with ASD.
1a. What is the pattern of parent-reported socio-communicative behavior and RRB in a
sample of children with NF1?
1b. Are there parent-reported socio-communicative behaviors or RRB that are more or less
problematic for children with NF1?
1c. What is the pattern of clinician-observed socio-communicative and RRB behavior in a
sample of children with NF1?
1d. Are there clinician-observed socio-communicative behaviors or RRB that are more or
less problematic for children with NF1?
1e. What proportion of children with NF1 meet criteria for an ASD (using both the ADOS-2
and ASI) in a sample of children with NF1?
Secondary Aim: To examine possible variables that may contribute to poor sociocommunicative behavior and RRB.
2a. Do intellectual functioning, attention, social cognition, and/or pragmatic language skills
predict socio-communicative behavior and RRB difficulties?
Hypotheses
It is hypothesized that moderate levels of parent-reported socio-communicative
difficulties and RRB will be endorsed on a measure of social responsiveness and RRB, but fewer
children with NF1 will meet or exceed the cutoff on ASD-specific screening measures. It is also
hypothesized that the majority of children with NF1 will demonstrate few clinician-observed
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socio-communicative difficulties or RRB and that there will few items on which more than half
of the sample demonstrates significant impairment. Finally, it is expected that variables that may
contribute to socio-communicative difficulties and RRB, such as intellectual functioning,
attention, social cognition, and pragmatic language, will be related to severity of social
responsiveness difficulties. Specifically, it is expected that the children with NF1 with lower
performance on these variables will also be the children who are more severely affected by
behavioral symptoms overlapping with ASD.
Participants
Participants included (1) 25 children between the ages of 9 and 13 diagnosed with NF1,
and (2) one parent of each child participant. Only children whose first and main language spoken
in the home was English were included in this study. Children whose first and main language
was not English were excluded because study measures and instructions were standardized and
normed using English speaking populations. Additionally, children who had recently (within 6
months) had a significant surgery (heart or brain surgery) were excluded from this study, given
that the effects of surgery could have an impact on their performance on study measures. Group
demographic data is provided in Table 1.
Procedures
Participants were recruited using three methods. First, fliers describing the study were
mailed to participants in our database who have participated in prior research with us and who
consented to be informed of future studies in our lab. After the fliers were sent, families were
called so that a member of the study staff could answer any questions they may have had about
the study. Second, potential participants were recruited through the several Midwestern
Neurofibromatosis Clinic. NF1 clinic directors shared a description of the study to families with
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children between the ages of 9 and 13 with a known diagnosis of NF-1. Parents who were
interested in participating or finding out more about the research were provided with a flier and
encouraged to contact the PI or study coordinator. Finally, a flier was posted to the national
Neurofibromatosis Research Registry and families within driving distance, who had noted their
interest in being contacted about possible research opportunities on the Registry, were emailed a
description of the study and a flier.
Participants who met eligibility requirements were schedule for an evaluation at the Child
Neurodevelopment Research Lab (CNRL) at the University of Wisconsin-Milwaukee or in a
quiet hotel conference room near their home. Participants were guided through the consenting
process and had an opportunity to ask questions or express concerns before agreeing to
participate. Prior to the assessment appointment, the consent form and questionnaires were
mailed to the family for parental completion. The questionnaires were designed to examine
social difficulties and ASD symptoms. Each child was administered an age-appropriate
neuropsychological battery by a trained member of the study team. Assessment sessions lasted
approximately 4 hours for all children, including time for breaks to minimize fatigue. All
assessment measures were administered to all children in the same order. Parents were
interviewed about their child’s behavior during their child’s assessment in an adjacent room.
Measures
All measures chosen for this study were developed for use with children 9 to 13 and are
widely used in pediatric assessment and research. All neuropsychological measures are normreferenced and have demonstrated strong psychometric properties, including good reliability and
validity. These measures have been used with both typically developing children and children
with a variety of developmental disorders. These measures were selected to pick up on both
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obvious impairments, as well as more subtle difficulties that are commonly found in children
with NF1. A detailed description of each measure is provided below and an overview of the
selected measures is listed in Table 2.
Social Responsiveness Scale – Second Edition (SRS-2: Constantino & Gruber,
2012). The SRS-2 is a parent questionnaire that measures social responsiveness difficulties and
RRB that are associated with ASD and quantifies their severity. The SRS-2 has demonstrated
evidence of good inter-rater reliability, high internal consistency, and convergent validity with
the ADI-R, ADOS, and SCQ (Constantino & Gruber, 2012). The SRS-2 utilizes T-scores based
on a gender-normalized, nationally representative standardization sample. Scores are provided
for five treatment subscales, including the Social Awareness, Social Cognition, Social
Communication, Social Motivation, and Restricted Interests and Repetitive Behavior (RRB)
subscales. There are also two DSM-5 compatible subscales, including the Social Communication
and Interaction (SCI) and Restricted Interests and Repetitive Behavior (RRB) subscales, which
allows for comparison of symptoms to DSM-5 ASD diagnostic criteria. Interpretation is based on
a single score, the SRS-2 Total Score, which reflects the sum of responses to all 65 items and
serves as a continuous severity index of social responsiveness and repetitive behaviors that are
indicative of ASD symptomatology. A Total Score of 76 or higher is considered severe and
strongly associated with clinical diagnosis of ASD. Scores of 66-75 are interpreted as indicating
moderate impairments and scores of 60-65 indicate mild impairments in social responsiveness.
Scores of 59 and below are considered to be within typical limits and are generally not associated
with clinically significant ASD symptomatology.
Social Communication Questionnaire – Lifetime (SCQ; Rutter, Bailey, & Lord,
2003). The SCQ is a parent-completed screening questionnaire that examines the level of ASD
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symptomatology. The SCQ was designed as a companion screening measure for the ADI-R. The
SCQ yields a raw score that is compared to a research derived cutoff score. Raw scores that are
equal to or greater than the cutoff score (cutoff = 15) indicates the possibility of ASD and,
therefore, the need of a more comprehensive evaluation. The SCQ demonstrates good reliability
and good agreement with the ADI-R (Berument et al. 1999).
Autism Symptom Interview (ASI; S. Bishop, personal communication with B. P.
Klein-Tasman, Jan. 12, 2015). The ASI is a newly developed structured interview based on the
ADI-R and the SCQ. It was developed by Bishop and colleagues (S. Bishop and C. Lord,
personal communication) with publication forthcoming. The ASI is a structured interview
conducted with caregivers that assesses the presence and frequency of ASD symptomatology in
preschool- and school-aged children. The measure was developed using questions from the ADIR and SCQ and preliminary data has demonstrated good sensitivity (82%) and specificity (92%)
when used in combination with the ADOS-2 classification (S. Bishop and C. Lord, personal
communication). Similar to the ADI-R, the ASI utilizes a cutoff score (cutoff = 38) to determine
ASD classification, with a range of raw scores from 0-116.
Autism Diagnostic Observation Schedule – 2nd Edition (ADOS-2; Lord, Rutter, Risi,
Gotham, & Bishop, 2012). The ADOS-2 is a semi-structured, standardized assessment of sociocommunication, social interaction, play/imaginative play, and RRB. It is considered the “gold
standard” observational assessment for diagnosing ASD and demonstrates good reliability and
validity (Lord et al, 2012). Based on observations made during the activities and interactions,
rating codes are assigned for several ASD related symptoms. A subset of the codes were
converted to algorithm scores that were then summed and used to complete a diagnostic
classification (i.e. non-spectrum, autism spectrum, autism) based on empirically-derived cutoff
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scores. Scores less than 7 were considered “non-spectrum”, scores between 7 and 9 were
considered “autism spectrum”, and scores greater than 9 were considered a classification of
“autism.” Additionally, the ADOS-2 provides a comparison score, which was developed as a
way of indicating the level or severity of autism spectrum-related symptomatology. The
comparison score ranges from 1 to 10, with a score of 1 indicating “minimal-to-no evidence” and
10 indicating “high evidence” of ASD symptomatology.
A graduate student who has been specifically trained to administer the ADOS-2 to
“research reliable” standards administered this measure. In order to insure the reliability of
scoring, 20% of cases were selected at random to be coded by another “research reliable”
graduate student or faculty member. Cohen's κ was run to determine if there was agreement
between the two coders on all ADOS-2 scores and codes. There was substantial agreement
between the two coders, κ = .72, p < .001. There was agreement on 93% of all ADOS-2 items
and 94% agreement on ADOS-2 algorithm items between coders.
Differential Ability Scales-Second Edition: School-Age Form (DAS-II; Elliot, 1990).
The DAS-II is a commonly used, comprehensive measure of cognitive abilities for children ages
7-0 to 17-11. The DAS-II is empirically derived and demonstrates excellent internal consistency,
test re-test reliability and correlates highly with other commonly used measures of cognitive
abilities (Elliot, 1990). The DAS-II provides normative data collected on a large representative
national sample and contains excellent floor and ceiling levels, making it appropriate for children
with neurodevelopmental disorders. This measure yields an overall composite score called the
General Conceptual Ability (GCA) standard score (mean of 100, standard deviation of 15) that is
equivalent to a full-scale IQ score. The GCA is broken down into three cluster scores, including
Verbal Ability, Nonverbal Reasoning Ability, and Spatial Ability. In this study, participants
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completed the core subtests for the School-Age Form (including Word Definitions, Verbal
Comprehension, Matrices, Sequential and Quantitative Reasoning, Recall of Designs, and
Pattern Construction) to yield a GCA.
NEPSY – Second Edition: Auditory Attention/Response Set (NEPSY-II; Korkman,
Kirk, & Kemp, 2007). The NEPSY-II is a widely used measure that assesses children’s
performance in areas of six theoretically derived domains, including Attention and Executive
Functioning, Language, Memory and Learning, Sensorimotor, Social Perception, and
Visuospatial function. Administration of selected subtests takes approximately 5-10 minutes and
is designed for children 3-16 years old. The Auditory Attention/Response Set (AA/RS) subtest
from the Attention domain has two parts; Auditory Attention was designed to assess sustained,
selective auditory attention and Response Set was designed to assess shifting and sustained
attention skills. This measure yields a combined scaled score (mean of 10, standard deviation of
3) that incorporates performance on the both portions of the task.
Clinical Evaluation of Language Fundamentals – Fifth Edition: Metalinguistic
(CELF-5 ML; Semel, Wiig, & Secord, 2014). The CELF-5 ML is a standardized measure with
good reliability and validity, designed to assess higher-level language skills, such as
understanding inferences, conversational speech, multiple word meanings, and non-literal
language (Semel, Wiig, & Secord, 2014). The CELF-5 ML was developed for children and
adults from 9-21 years. The CELF-5 ML has five subtest including the Metalinguistic Profile,
Making Inferences, Conversation Skills, Multiple Meanings, and Figurative Language.
Performance scores for Making Inferences (MI) and Conversation Sills (CS) subtests can be used
to derive a Meta-Pragmatic Language (MPLI) index score. For this study, the MPLI was used
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and the MI and CS subtests were administered in order to examine pragmatic language skills.
This measures utilized standard scores for both the subtests and the index.
Cogstate Research Battery (Cogstate; http://www.cogstate.com), selected subtests.
The Cogstate battery is a commercially available, computerized cognitive testing system
designed specifically for the use in research studies. Cogstate tasks have been shown to be highly
reliable, repeatable, and sensitive. The entire Cogstate testing battery targets a wide range of
cognitive domains, including processing speed, attention, executive function, and socialemotional cognition. For this study, the Visual Attention/Vigilance, Attention/Working Memory,
and Social Cognition tasks were administered. For the Visual Attention/Vigilance domain, the
Identification Task (IT) was completed. This task takes approximately 2 minutes to complete and
yields an accuracy score in which higher scores indicate better performance. This task was
designed to assess simple visual attention and vigilance/concentration. Within the Attention
domain, the One Back Task (OBT) and Two Back Task (TBT) were completed. The OBT and
TBT take approximately 4 minutes to complete and produce an accuracy score in which higher
scores indicate better performance. These two tasks were designed to assess working memory
and sustained visual attention skills. Within the Social Cognition domain, the Social-Emotional
Cognition Task (SECT) was completed. The SECT takes approximately 7 minutes to complete
and produces an accuracy score in which higher scores indicate better performance. This task
was designed to assess emotional facial expression and eye expression recognition.
Background Questionnaire. The CNRL Background Questionnaire is a parentcompleted questionnaire that was used to collect demographic information, which may aid in
analysis of data (examining differences based on, for example, parental education or child
medical history).
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Results
In this section, the data from parent-reported and clinician-observed measures of sociocommunicative difficulties for school-aged children with NF1 are provided. First, descriptive
statistics examining group demographics will be provided. Next, descriptive statistics of parentreported and clinician-observed socio-communicative difficulties, as well as, item-level analysis
of ASD symptomatology on the ASI and ADOS-2 will be detailed. Additionally, descriptive
statistics of intellectual functioning, attention, social cognition, and pragmatic language skills
will be provided. Finally, relations between the severity of ASD symptoms and those variables
that may contribute to socio-communicative difficulties will be examined.
The data were analyzed using IBM SPSS for Windows, version 22. When relevant,
findings are interpreted with respect to both statistical significance and effect size. The
frequencies of scores on individual items will be reported. Since current DSM-5 diagnostic
criteria focuses primarily on the presence/absence of symptoms, ASI and ADOS-2 items will be
examined with regard to the presence (scores of 1, 2, or 3) or absence (score of 0) of
endorsement. Items for which more than half (>50%) of the sample endorsed the presences of a
symptom (receives a score/code of 1, 2, or 3) will be especially highlighted and will be
considered “common.” Items that were endorsed as present (endorsed by 33-50% of the sample),
will also be discussed in order to add to the clinical utility of findings. Spearman’s rho was used
when correlational analyses were conducted and interpretations of correlation effect size (Cohen,
1988) are as follows: small = 0.1 – 0.3; medium = 0.3 – 0.5; large = 0.5 – 1. The stability of the
correlations must be interpreted with caution given the small sample size.
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ASD Symptomatology in Children with NF1
Research Question 1a: What is the pattern of parent-reported socio-communicative
behavior and RRB in a sample of children with NF1? A summary of parent-reported SRS-2
scores is detailed in Table 3. One parent did not complete the SRS-2; therefore, all analyses for
the SRS-2 were completed using 24 children. Group mean scores fell in the normal range for all
domain scores; however, independent one-sample t-tests indicated significantly higher scores
than the normative mean on the Social Awareness, t(23) = 3.05, p > .01; Social Cognition, t(23)
= 2.38, p = .03; and Social Communication, t(23) = 2.66, p = .01, domains; and on the Social
Communication, t(23) = 2.54, p = .02; and Total Score, t(23) = 2.64, p = .02, indexes. Figure 1
details the distribution of normal (≤ 59), mild (60-65), moderate (66 – 75), and severe (≥ 76)
problems reported by parents on the SRS-2. There were no children whose parents reported
severe difficulties on the Social Awareness and Social Motivation domains, nor on the RRB,
SCI, or Total Score indexes. There were also no domains in which over half of parents reported
mild, moderate, or severe social problems. There were no difference in SRS-2 Total Score in
relation to age, r = .34, n = 24, p = .10; nor sex, F(1, 22) = 0.15, p = .70).
Of the 25 children with NF1 whose parents completed the SCQ, zero parents reported
ASD symptomatology that met or exceeded the cutoff score (≥ 15). SCQ scores ranged from 0 to
14, with a mean of 4.12, median of 3.00, and mode of 0. Figure 2 details the distribution of SCQ
scores. Of the 25 children with NF1 whose parents completed the ASI, 3 (12%) met or exceeded
the cutoff score (≥ 38). ASI scores ranged from 5 to 50, with a mean of 21.12, median of 20.00,
and mode of 11, 15, 18, 24, and 30 (frequency of 2 each). Figure 3 details the distribution of ASI
scores. There were no differences between SCQ and ASI Total Scores in relation to age, SCQ: r
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= .13, n = 25, p = .54, ASI: r = .36, n = 25, p = .07; nor sex, SCQ: F(1, 23) = 1.37, p = .25, ASI:
F(1, 23) = 0.95, p = .34.
Research Question 1b: Are there parent-reported socio-communicative behaviors or
RRB that are more or less problematic for children with NF1? The frequencies of scores on
ASI individual items are reported in Table 4. There were 7 out of 17 items from the Social
Communication domain and 5 out of 7 items from the Peer Interaction domain in which more
than half of the children with NF1 demonstrated some degree of difficulty, indicated by a score
of 1, 2, or 3. Parent endorsement of awkward social interactions (76%), lack of use of gestures
(80%), lack of group play with peers (52%), limited asking for information (76%), perseverative
topics of conversations (68%). prefers time alone (60%), lack of nodding (60%), limited
socializing with peers (56%), lack of sharing (56%), limited approaching other children (52%),
use of odd phrases (60%) and lack of pointing (92%) were common for children with NF1. There
were 0 out of 5 items from the RRB domain in which over half of parents of children with NF1
reported as problematic. These findings suggest that difficulties with peer interactions are the
most prevalent difficulty and RRB are the least problematic area of impairment reported by
parents of children with NF1.
There were eight additional items for the Social Communication and Peer Interaction
domains in which one-third to one-half of parents endorsed some level of difficulty, including,
inappropriate direct gaze (44%), response to conversational leads (40%), intonation (40%), facial
expressions (40%), responses to distress (48%), social responses (48%), and responses to
children (44%). There were two items from the RRB domain in which elevations were noted by
parents including the initiation of appropriate activities (40%) and sensory aversions (40%).
Results indicate that while there was not an overwhelming endorsement of ASD
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symptomatology, difficulties in SCI and RRB are reported by parents for a minority of children
with NF1.
The ASI is a new measure with sparse research to support its reliability and validity.
Therefore, the relation between ASI and SRS-2 Total Scores were examined to explore whether
parent report of socio-communicative behaviors was similar across measures. There was a large,
significant correlation of .84 (p < .001) between the ASI and SRS-2 Total Scores, suggesting that
parents are reporting similar behaviors on the ASI and SRS-2.
Research Question 1c: What is the pattern of clinician-observed sociocommunicative behaviors and RRB in a sample of children with NF1? Of the 25 children
with NF1 who were administered Module 3 of the ADOS-2, 24 (96%) were classified “nonspectrum” on the Overall Total Score. Figure 4 details the distribution for ADOS-2 domain
scores. There were no differences in ADOS-2 Total Scores in relation to age, r = .05, n = 25, p =
.82; however, there was a significance difference in ADOS-2 Total Scores by sex, with males
demonstrating more difficulties on the ADOS-2 than females (Males: M = 2.31, SD = .68;
Females: M = .793, SD = .23), F(1, 23) = 5.35, p = .03).
Research Question 1d: Are there clinician-observed socio-communicative behaviors
or RRB that are more or less problematic for children with NF1? The frequencies of scores
on ADOS-2 algorithm items are reported in Table 5. There were no items in which over onethird of children with NF1 demonstrated problematic behaviors. Additionally, there were no nonalgorithm items in which over one-third of the children with NF1 demonstrated significant
problematic behaviors.
Research Question 1e: What proportion of children with NF1 meet criteria for an
ASD (using both the ADOS-2 and ASI) in a sample of children with NF? No children met or
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exceeded cutoff using the algorithms for “ASD” and “autism” classifications on both the ADOS2 and ASI. While there were no children who met classification for ASD on the ADOS-2 and
ASI, there were four (16%) children who met or exceeded cutoff on one ASD screening
measure. Table 6 details scores for those four children.
Relations to Socio-Communicative Behavior in Children with NF1
Research Question 2: Do intellectual functioning, attention, social cognition, and/or
pragmatic language skills predict socio-communicative behavior and RRB difficulties?
Table 7 describes group performance on variables that may play a role in social responsiveness
and RRB. Children with NF1 generally demonstrated average performance on measures of
intellectual functioning, attention, and pragmatic language abilities. One-sample t-tests indicate
that children performed significantly below the normative mean on intellectual functioning
(GCA: t(24) = -3.94, p > .001), attention (AA/RS: t(24) = -2.72, p = .01), and understanding
inferences (MI: t(24) = -2.06, p = .05).
In order to better understand what variables could help explain social responsiveness
difficulties and RRB reported by parents of children with NF1, relations between the SRS-2
Total Score and the variables described above were investigated using Pearson product-moment
correlation coefficients. Preliminary analyses were performed to ensure no violation of the
assumptions of normality, linearity, and homoscedasticity. The SRS-2 is a well-established
measure that has demonstrated good reliability and validity, and given the high correlation found
between the SRS-2 and ASI in this study, the SRS-2 was chosen as our primary social
impairment measure. The SRS-2 Total Score was chosen over the ADOS-2 Severity Score since
there was very little variability in ADOS-2 Severity Scores. The SRS-2 Total Score was also
chosen over the ASI Total Score given that the ASI is a new measure that has not been
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rigorously researched. ASI correlational analyses were also conducted for thoroughness and can
be found in Appendix B. Results were very similar across the two measures; therefore, only the
results of SRS-2 analyses are presented here.
Results indicated medium, negative correlations between SRS-2 Total Score and GCA (r
= -.53, n = 24, p = .01), SECT (r = -.46, n = 24, p = .02), and MPLI (r = -.53, n = 24, p = .01).
Given the significant correlation between the SRS-2 Total Score and MPLI, additional
correlational analyses were investigated utilizing the MLPI subtest scores. Results highlighted a
large, negative correlation between the SRS-2 Total Score and MI (r = -.0, n = 24, p < .01).
There was no significant correlation between the SRS-2 Total Score and CS (r = -.34, n = 24, p =
.10).
Multiple linear regression analysis was used to test if intellectual functioning (GCA),
social cognition (SECT), and pragmatic language (MI) performance predicted parent-reported
social responsiveness difficulties (SRS-2 Total Score). Results indicated that the three predictors
explained 36% of the variance (Adjusted R2 = .36, F(3, 23) = 5.31, p < .01). It was found that MI
significantly predicted parent report of social responsiveness (β = -.44, p = .03) and uniquely
explained 38% of the variance found in the SRS-2 Total Score.
Discussion
The primary aim of this study was to examine parent-reported and clinician-rated levels
of ASD symptomatology in children with NF1 using a diagnostic assessment of ASD symptoms.
A secondary aim was to examine possible variables that may contribute to socio-communicative
difficulties and RRB, such as intellectual functioning, attention, social cognition, and pragmatic
language skills. As hypothesized, results indicate that parents of approximately 30% of children
with NF1 reported significant social difficulties on a measure of social responsiveness and RRB;
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however, few parents endorsed enough ASD symptomatology on ASD-specific screening
measures to suggest the presence of an ASD. Additionally, as hypothesized, low rates of ASD
symptoms were endorsed on a clinician-observed ASD diagnostic measure. Relations between
severity of social responsiveness and RRB and intellectual functioning, social processing, and
pragmatic language skills were found. Contrary to our original hypothesis, there was no
significant relation between the severity of social responsiveness and RRB and attention. These
findings are both similar and dissimilar to previous literature which indicated higher levels of
social responsiveness difficulties and RRB and higher rates of ASD in children with NF1
(Adviento et al., 2013; Garg et al., 2013a; Garg et al., 2013b; Garg et al., 2015; Huijbregts &
Sonneville, 2011; Plasschaert et al., 2014; Tinker et al., 2015; Walsh et al., 2012). Potential
explanations for these findings will be provided below, along with limitations and future
directions, and conclusions.
Parental Report of Social Difficulties and ASD Symptomatology
The present study found fewer children with marked parent-reported elevations in social
responsiveness difficulties and RRB in a sample of children with NF1 than observed in prior
research. Previous studies found that 13-33% of parents of children with NF1 endorsed severe
(T-score > 75) difficulties, whereas, this study found no children whose SRS-2 Total Score fell
in the severe range (See Table 8 for a brief summary of SRS findings from previous studies).
Furthermore, rates of severe impairment across all domains of the SRS-2 were very low (see
Figure 1), including in the RRB index. Additionally, in contrast to previous studies, our results
found that no children met or exceeded cutoff on the SCQ per parent report. Very low levels of
ASD symptomatology was reported by parents on the SCQ, with raw scores ranging from 0-14
(see Figure 2). This is different from previous research by Adviento et al. (2013) and Tinker et
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al. (2014) in which 11% and 13% of children with NF1, respectively, screened positive for a
possible ASD on the SCQ. However, Tinker et al. (2014) noted that while 13% of children with
NF1 screened positive on the CAST, this rate did not differ significantly from general population
data (5.8%; Williams et al., 2005).
One reason we may have not seen as many severe social responsiveness difficulties and
RRB as previous studies is because previous studies included a wider age range of participants,
with some studies including toddlers and adults in their sample (see Table 8 for a brief outline of
previous SRS study samples). It may be that we would see an increase in severe social
responsiveness difficulties and RRB with a younger or older sample of children. However,
Plasschaert et al. (2014) found that age was significantly correlated to social responsiveness and
ASD symptomatology, with more social responsiveness difficulties reported with increasing age.
These authors found significantly less social problem behaviors reported in children with NF1
before the age of 8 and reported that social problems and ASD symptomatology seemed to peak
between 11-13 years. Therefore, it seems unlikely that our restricted age range would explain
why we did not find elevated levels of severe social responsiveness difficulties in children with
NF1. Additionally, this study sample was small compared to previous studies (Ns ranging from
30-109) and larger samples are needed to replicate our findings. Finally, potential ascertainment
biases, from this study and/or at the screening and follow-up stage of previous studies, may be
contributing to the discrepancy in results.
In sum, in contrast with previous research, results from the current study indicate that
while children with NF1 do show mild to moderate levels of social responsiveness difficulties
compared to population norms, they do not appear to demonstrate a high frequency of severe
social responsiveness difficulties or problematic RRB. Furthermore, results indicate that children
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with NF1 may display more ASD symptoms than population norms, which makes them appear
to be at a higher risk for a diagnosis of ASD; however, they may not actually meet threshold for
a positive screen on ASD-specific screening measures.
Overall Pattern of Performance on ASD Diagnostic Measures
Based on item analysis of parent-reported ASD symptomatology using the ASI,
difficulties were commonly observed (for more than 50% of the sample) in the Social
Communication domain on items such as asking for information, using odd phrases, pointing to
objects of interest, using gestures, nodding, and sharing with others, and especially in the Peer
Interaction domain, including items such as preferring to spend time alone, approaching children,
joining in group play with peers, socializing with peers, and awkward interactions with peers.
Additional symptoms within the Social Communication and Peer Interaction domains were
endorsed for 33-50% of the sample, including ineffective eye contact when communicating, lack
of social chat, respond to questions and conversational leads inappropriately, and inappropriate
intonation when speaking. Additionally, parents reported some RRB behaviors in a minority of
children with NF1, including poor initiation of activities (40%) and sensory aversions (40%).
These findings are particularly important clinical findings because it highlights that while the
majority of children with NF1 are not demonstrating significant ASD symptomatology for a
diagnosis, especially in the RRB domain, there is a minority of children who have social
communication difficulties.
Children with NF1 also showed very few difficulties on the ADOS-2, with the majority
of algorithm items receiving a score of 0. Some very mild difficulties were noted on three
algorithm items, including slight difficulties with reporting events (32%), use of gestures (20%)
and quality of social responses (20%). Overall, this study found very low rates of ASD
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symptomatology and many prosocial, socio-communicative behaviors when using a clinicianrated ASD diagnostic measure. Results indicated that severity of ADOS-2 Total Scores was
related to sex, with males demonstrating more ASD symptoms than females. This is similar to
previous studies that found a higher rate of ASD symptomatology in boys with NF1 (Garg et al.,
2013b, Adviento et al., 2013; Plasschaert et al. (2014).
Contrary to previous literature, there were no children who met criteria for diagnosis of
ASD when combining the ASI and ADOS-2 results in the current sample. Garg et al. (2013a)
found that 30% of their sample of children with NF1 met criteria for ASD and an additional 28%
met criteria for broad ASD when using the more relaxed CPEA diagnostic guidelines.
Plasschaert et al. (2014) found a minimum prevalence estimate of 27% of ASD in their sample of
children with NF1 based on DSM-IV-TR diagnostic criteria. The authors indicated that 15% of
the group presented with minimal ASD symptoms, 48% presented with moderate ASD
symptoms, and 4% presented with severe ASD symptoms. However, in contrast, Adviento et al.
(2013) reported that only 3% of their sample of children with NF1 were diagnosed with ASD or
broad ASD after completing a comprehensive evaluation that included the ADOS and ADI-R.
One reason this study may have found fewer children meeting criteria for ASD is due to
our stringent diagnostic criteria. For this study, we required that in order to meet criteria for
ASD, a child would have to meet or exceed ASD cutoff scores on both the ASI and ADOS-2 and
meet criteria based on DSM-5 diagnostic criteria. However, most previous studies relied on
DSM-IV-TR ASD diagnostic criteria and/or ADOS-G classification (Adviento et al., 2013;
Plasschaert et al., 2014), which did not require the presence of RRB in order to meet criteria of
ASD. Additionally, Garg et al., 2013 relied on an ASD diagnostic classification that was based
on the CPEA algorithm. This included children who meet criteria for Autism, Asperger’s, and
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broad-ASD, who do not necessarily have to meet original cutoff scores on diagnostic measures
to fulfill diagnostic criteria (Lainhart et al. 2006; see Appendix A for CPEA diagnostic criteria).
However, even with these diagnostic criteria differences in mind, the majority of children with
NF1 in this study presented with very “clean” ADOS-2 scores (indicated by the lowest possible
severity score of 1). There was a small proportion (12%) of children who had severity scores
higher than 1. Two children had severity scores of 3, which falls in the “low evidence of an
ASD” category and one child who had a severity score of 5, which falls in the “moderate
evidence of an ASD” category. This would suggest that while the majority of children with NF1
present with very few ASD symptoms, some did show evidence of mild to moderate ASD
symptomatology. The rate of even mild to moderate ASD symptomatology, however, is
considerably lower than the rate of ASD diagnoses in much of the previous literature. Our
findings are most consistent with those of Adviento et al. (2013) who found low rates of ASD.
Furthermore, while the results of the current study indicate that children with NF1 are not
more likely to screen positive for ASD than children without NF1, we did find some evidence of
elevated ASD symptomatology in children with NF1. Thirty-percent of parents reported elevated
rates of social responsiveness difficulties and RRB on the SRS-2, and, as noted in the Results
section, four children with NF1 met or exceeded cutoff on at least one ASD screening or
diagnostic measure (see Table 6). Three children met or exceeded cutoff on the ASI Total Score
and one child met classification of Autism Spectrum on the ADOS-2 Overall Score; however,
this child did not display any RRB symptoms and therefore did not meet for criteria for ASD. In
fact, RRB symptoms were only identified in 1 of the 25 children assessed with the ADOS-2.
Given the few RRB symptoms reported by parents of children with NF1 and noted by clinicians
during the ADOS-2, it seems possible that the new DSM-5 diagnosis of SCD may more
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accurately describe the social impairments seen in the NF1, as suggested by Garg et al. (2015).
Children with SCD have significant problems using verbal and nonverbal communication for
social purposes, leading to impairments in their ability to effectively communicate, participate
socially, maintain social relationships, or otherwise perform academically or occupationally
(American Psychiatric Association, 2013).
Overall, our results suggest that children with NF1 demonstrate some sociocommunicative difficulties and RRB per parent and clinician report; however, those difficulties
are largely not severe nor pervasive enough to meet DSM-5 criteria for ASD. Children with NF1
do not appear to be at a significantly higher risk of developing an ASD. However, given that the
social responsiveness difficulties that parents are reporting in children with NF1 are falling
largely in the Social Communication and Peer Interaction domains, a diagnosis of SCD may be a
more appropriate description of the kind of social difficulties some children with NF1 face. The
hallmark difficulties present in SCD include deficits in using communication for social purposes,
the inability to match communication style to match the social context, following the rules for
conversation, and difficulties in understanding what is not explicitly stated. These deficits in
social communication manifest in functional limitations in effective communication, social
participation, and developing and maintaining peer relationships (American Psychiatric
Association, 2013).
Relations between Social Responsiveness, RRB, and Related Variables
Results from this study are similar to previous studies that examined relations between
social responsiveness and RRB and intellectual functioning, attention, and social processing.
Results indicate that children with NF1 are demonstrating low scores on measures of intellectual
functioning, attention, and social information processing when compared to the normative mean.
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These findings are congruent with Huijbregts et al. (2010) and Huijbregts and Sonneville (2011)
who found that children with NF1 had difficulties on profile facial recognition and matching
facial emotions, suggesting that children with NF1 have difficulty with bottom-up encoding of
social stimuli. Additionally, results from the current study found that overall intellectual
functioning and difficulties with social information processing on the SECT were significantly
related to social responsiveness difficulties reported by parents on the SRS-2. Interestingly,
contrary to our original hypothesis, attention difficulties were not significantly related to social
responsiveness. These findings do still align with the results of Huijbregts et al. (2010) and
Huijbregts and Sonneville (2011) which suggested that attention deficits do not determine social
information processing difficulties in NF1 and that there appear to be vulnerabilities in both topdown, cognitive control, and bottom-up, social information processing difficulties in NF1.
Results from this study also suggest that children with NF1 are demonstrating
impairments in pragmatic language skills, and more specifically, the ability to interpret
inferences. Not only did the results of this study find that children with NF1 are performing in
the low average range on a making inferences task, but those difficulties uniquely explained 38%
of the social responsiveness difficulties reported by parents on the SRS-2. These findings further
support the notation that a diagnosis of SCD may be more appropriate to capture the social
communication difficulties of children with NF1. Previous studies have found that language
skills appear to be an area of weakness in preschool and school-aged children with NF1 (Brei,
Klein-Tasman, Schwarz, & Casnar, 2014; Dilts et al., 1996; Hyman et al., 2005; Lorenzo,
Barton, Acosta, & North, 2011; Mazzocco et al., 1995); however, no studies have examined the
role of pragmatic language abilities specifically in children with NF1. The results of this study do
mirror the results found by Pride et al. (2014) which found relations between social dysfunction

41

and emotion recognition and the ability to understand paradoxical sarcasm in adults with NF1.
More research in this area is needed to see if these findings generalize, given this study utilized a
small sample size, and only included two pragmatic language tasks. However, it seems that
pragmatic language deficits may help explain why many parents of children with NF1 are
reporting social difficulties and that those difficulties are being carried into adulthood.
Limitations and Future Directions
The present study provides clinically relevant information about the severity and
frequency of ASD symptomatology a sample of children with NF1 and identifies a few variables
that may contribute to elevated rates of social responsiveness difficulties and RRB reported by
parents. However, there are limitations in the study design that point to areas for improvement in
future research in this domain. First, this study utilized a relatively small sample size that may
have hindered our ability to identify significant results. Recruiting large cohorts of children with
NF1 is difficult because many of the clinical manifestations of NF1 are age-dependent and some
children may not be referred to a NF-specific clinic until significant medical manifestations
develop. This study attempted to address this barrier by emailing potential participants through
the NF Research Registry that may include children whom do not belong to a NF-specific clinic,
in order to reach a wider range of potential participants. However, response was generally
limited. Future studies employing larger sample sizes would improve power and generalizability
of results.
Second, this study relied solely on maternal report of social difficulties. A multiinformant approach that included more fathers, teachers, and peer ratings would help
characterize social difficulties in different social contexts and environments. This is especially
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important given previous research suggests that teachers are reporting fewer social
responsiveness difficulties and RRB in the school setting.
Third, this study restricted participation to only children with NF1 between the ages of 913. We chose to only include children in this narrow age range because previous research
suggested that social difficulties reported by parents of children with NF1 are most pronounced
in children 8 and older (Plasschaert et al., 2014). Given the barriers to recruitment in NF1
research, we hoped that by recruiting children in this age range, we would maximize our
inclusion of children with social difficulties, and thus, justify the completion of a comprehensive
ASD diagnostic evaluation. However, by restricted the age range we restrict the generalizability
of results. Therefore, future research examining ASD symptomatology in children from a wider
age range would help better characterize the developmental course of the presence or absence of
ASD symptomatology in children with NF1.
Fourth, the majority of children in this study (78%) presented with a sporadic verses
familial mode of inheritance. Given that approximately half of NF1 cases are identified as caused
by a sporadic mutation and half are caused by familial inheritance, it is generally preferred to
have a similar distribution in the mode of inheritance in research. Thus far, there does not seem
to be a relation between mode of inheritance and social responsiveness or ASD symptomatology
(Adviento et al., 2013; Garg et al., 2013b; Garg et al., 2013a; Plasschaert et al., 2014; Tinker et
al., 2014; Walsh et al., 2013); however, the skewed distribution of this study could affect the
interpretation of the results. Future studies would benefit from a more even distribution of
sporadic verse familial mode of inheritance in order to control for a potential confound.
Fifth, this study relied on the ASI, as opposed to the ADI-R, for our diagnostic measure of
parent-reported ASD symptomatology. As noted in the Methods section, the ASI is a relatively
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new measure that is still building research support for its reliability and validity. The results of
the present study found that the ASI correlated well with the SRS-2, lending support for its
reliability. However, there are many important differences between the ASI and ADI-R that must
not be overlooked. The ADI-R is a semi-structured interview that is rated by the clinician, based
on parent responses to questions. The clinician is allowed to rephrase questions and ask for
example behaviors in order to decide on the most appropriate code for that item. The ASI has
less flexibility and relies solely on the parent to interpret and select the best code for each item.
The ASI does provide more detail, in terms of frequency of behaviors, than other ASD screening
measures, which makes it a better measure for examining ASD symptomatology. However,
parents may misinterpret items or may not understand the subtle differences in sociocommunicative behaviors that the ASI assesses. Therefore, future studies may benefit from
including a clinician-rated measure of developmental history and ASD symptomatology, such as
the ADI-R, in order to ensure the accuracy of parental understanding of subtle sociocommunicative behaviors.
Finally, this study used published normative data as a comparison when examining SRS2 scores. There may be differences between this study sample with regards to socioeconomic
status and intellectual functioning that may have an impact on score interpretation. Future
research that utilizes a control group of unaffected children and a comparison group of children
with ASD (without NF1) from the community would help control for this limitation.
Summary
Social problems are a common concern of parents of children with NF1 and recent
studies have demonstrated elevations of ASD symptomatology in school-aged children with
NF1. In this study, parent-reported and clinician-observed ASD symptomatology and relations to
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risk factors for social responsiveness difficulties and RRB were examined. We explored these
symptoms at a global level (using cutoff scores) and detailed level (using item analysis) using the
ASI and ADOS-2. Overall, results suggest that parents are observing mild to moderate social
responsiveness difficulties in school-aged children with NF1, but report few ASD-specific
symptomatology on screening and diagnostic measures. Additionally, clinicians observed few
severe or pervasive ASD symptoms on the ADOS-2. Relations between parent report of social
responsiveness and intellectual functioning, social information processing, and pragmatic
language were found.
Although elevated scores on the SRS-2 were found in our sample of children with NF1, no
child met diagnostic threshold for a DSM-5 diagnosis of ASD. This suggests that there are
important differences in the socio-communicative characteristics between the social difficulties
described by parents of children with NF1 and those described by parents of children with ASD.
It remains unclear whether the elevations on the SRS-2 are a result of over-reporting of ASD
symptomatology, misinterpreting behaviors as symptoms of ASD, a lack of awareness of subtle
socio-communicative behaviors (such as nodding, pointing or gesturing), or whether children
with NF1 truly exhibit social deficits similar to those seen in ASD. Regardless, the results of this
study indicate that the social difficulties described by parents of children with NF1 may overlap
with ASD symptomatology, they are not indicative of a true ASD diagnosis.
Implications for Clinical Practice
The results of this study highlight the importance of the use of a comprehensive assessment
of socio-communicative difficulties when a child with NF1 presents with social difficulties in
clinic. Quick diagnosis of ASD based solely on questionnaire data may lead to misclassification
of children with NF1, given ASD symptoms are often endorsed by parents. The social difficulties
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described by parents appear to be related to other risk factors, such as pragmatic language
difficulties, social information processing difficulties, or intellectual functioning, rather than to
true ASD socio-communicative difficulties and RRB. Nonetheless, the results of this study
underline the need to develop interventions to address the social difficulties seen in children with
NF1 and that these interventions are not dependent on a diagnosis of ASD. Targeting weaknesses
in social language and social information processing may be a promising starting point for
intervention development.

46

Table 1.
Participant Demographic Data (n = 25)
Variable
Score/Percent
11.36 (1.56)
Mean Age (SD)
Sex (%)
Males
13 (52)
Females
12 (48)
Ethnicity (%)
Caucasian
20 (80)
African American
3 (12)
Asian
1 (4)
Biracial
1 (4)
Mother’s Education (%)
HS Diploma
4 (16)
Some College
5 (20)
College Degree
4 (16)
Post College
12 (48)
90.84 (11.63)
Mean GCA (SD)
5.36 (1.71)
Current Grade (SD)
Special Education (%)
Yes
13 (52)
No
12 (48)
Previous Diagnoses (%)
None
17 (68)
ADHD
5 (20)
MD, Language Disorder
1 (4)
RD, Language Disorder
1 (4)
MD, RD, Language Disorder
1 (4)
NF1 Diagnosis (%)
Sporadic
18 (72)
Familial
7 (28)
Note: MD = Math Disorder; RD = Reading Disorder.
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Table 2.
Summary of Study Measures
Domain
Measure
Social Responsiveness and RRB Social Responsiveness Scale-2 (SRS-2)
Autism Symptomatology
Social Communication Questionnaire (SCQ)
Autism Symptoms Interview (ASI)
Autism Diagnostic Observation Schedule-2 (ADOS-2)
Intellectual Functioning
Differentials Ability Scale-II (DAS-II)
Vigilance/Concentration
Cogstate: Identification Task (IT)
Attention/Working Memory
Cogstate: One Back Task (OBT) & Two Back Task (TBT)
NEPSY-II: Auditory Attention/Response Set (AA/RS)
Social Cognition
Cogstate: Social-Emotion Cognition Task (SECT)
Pragmatic Language
CELF-5 MPLI: Making Inferences (MI) &
Conversation Skills (CS)
NF1 Related Factors
Background Questionnaire
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Table 3.
SRS-2 Descriptive Statistics and One-sample t-tests
Domain/Index
M (SD)
Social Awareness
56.25 (10.05) ++
Social Cognition
55.58 (11.49) +
Social Communication
56.13 (11.27) +
Social Motivation
52.00 (11.17)
Restricted, Repetitive Behaviors
53.54 (8.71)
Social Communication & Interaction Index 55.79 (11.16) +
SRS-2 Total Score
55.76 (10.65) +
Significantly higher than normative mean: + p < .05, ++ p < .01
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d
0.63
0.56
0.61
0.20
0.36
0.58
0.58

Table 4.
ASI Algorithm Item Scores

Social Communication
Direct Gaze
Social Chat
Responds to Questions
Responds to Conversation Leads
Starting Conversation
Asking for Information
Perseveration
Odd Phrases
Intonation
Pointing
Gestures
Nodding
Inappropriate Facial Expressions
Sharing
Response to Distress
Appropriate Social Responses
Inappropriate Social Responses
Peer Interaction
Time Alone
Approaching Children
Response to Children
Group Play with Peers
Socializing with Peers
Awkward Interactions
Maintaining Friendships
Restricted & Repetitive Behaviors
Initiation of App Activities
Sensory Aversions
Unusual Sensory Interests
Circumscribed Interests
Routines

Absent

Present

(score 0)

(score 1, 2, 3)

Symptom Severity
Score 2

Score 3

N

%

N

%

N

Score 1

%

N

%

N

%

14
21
19
15
17
6
8
10
15
2
5
10
15
11
13
13
13

56
84
76
60
68
24
32
40
60
8
20
40
60
44
52
52
52

11
4
6
10
8
19
17
15
10
23
20
15
10
14
12
12
12

44
16
24
40
32
76
68
60
40
92
80
60
40
56
48
48
48

6
3
5
9
8
9
9
11
6
4
12
9
7
6
8
8
11

24
12
20
36
32
36
36
44
24
16
48
36
28
24
32
32
44

5
1
1
1
0
10
3
2
4
13
8
4
3
6
4
3
0

20
4
4
4
0
40
12
8
16
52
32
16
12
24
16
12
0

0
0
0
0
0
0
5
2
0
6
0
2
0
2
0
1
1

0
0
0
0
0
0
20
8
0
24
0
8
0
8
0
4
4

10
12
14
12
11
6
17

40
48
56
48
44
24
68

15
13
11
13
14
19
8

60
52
44
52
56
76
32

12
9
8
9
8
14
3

48
36
32
36
32
56
12

1
4
3
3
4
2
1

4
16
12
12
16
8
4

2
0
0
1
2
3
4

8
0
0
4
8
12
16

15
15
23
17
18

60
60
92
68
72

10
10
2
8
7

40
40
8
32
28

4
5
0
1
4

16
20
0
4
16

3
5
1
4
1

12
20
4
16
4

3
0
1
3
2

12
0
4
12
8

Note: Items printed in red indicate “common” behaviors (over half of sample endorsed the presence of that
behavior). Scores of “0” indicate that parents reported no abnormality in that behavior. Items that required reverse
coding have been converted to scores in order to reflect correct symptom severity levels.
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Table 5.
ADOS-2 Algorithm Scores

Social Affect
Reporting of Events
Conversation
Gestures
Unusual Eye Contact
Facial Expressions
Shared Enjoyment
Quality of Social Overtures
Quality of Social Responses
Amount Reciprocal Social Communication
Overall Quality of Rapport
Restricted and Repetitive Behavior
Stereotyped/Idiosyncratic Words
Unusual Sensory Interest
Hand, Finger, Complex Mannerisms
Excess Interest Unusual/Specific Topics

Absent

Present

(score 0)

(score 1, 2)

Symptom Severity
Score 1

Score 2

N

%

N

%

N

%

N

%

17
21
20
24
23
25
24
20
23
23

68
84
80
96
92
100
96
80
92
92

8
4
5
1
2
0
1
5
2
2

32
16
20
4
8
0
4
20
8
8

8
4
4
-2
0
1
5
2
2

32
16
16
-8
0
4
20
8
8

0
0
1
1
0
0
0
0
0
0

0
0
4
4
0
0
0
0
0
0

24
24
25
22

96
96
100
88

1
1
0
3

4
4
0
12

1
1
0
3

4
4
0
12

0
0
0
0

0
0
0
0

51

Table 6.
Descriptive Scores for Meeting/Exceeding Cutoff on ASD Screening Domains
SCQ Total
ASI Total
SA
RRB
ADOS-2 Overall
(cutoff = 15) (cutoff = 38) Total
Total
(cutoff = 7/9)
8
1
0
1
Child 1
38*
14
0
0
0
Child 2
39*
10
4
1
5
Child 3
50*
2
22
8
0
Child 4
8*
* Denotes met/exceeded cutoff on that domain score
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ADOS-2
Severity
1
1
3
5

Table 7.
SRS-2 Total Score Correlations to Related Variables
Score
M
SD
ASI Total Score
Range
21.12
11.26
GCA
Standard 90.84 + 11.63
Identification Task
Accuracy
1.31
0.22
AA/RS Combined
Scaled
8.16 + 3.39
One Back Task
Accuracy
1.15
0.25
Two Back Task
Accuracy
0.99
0.25
Cogstate SECT
Accuracy
0.94
0.20
MPLI
Standard 98.76
17.01
Making Inferences
Scaled
8.60 + 3.39
Conversation Skills
Scaled
10.92
3.34
Significantly higher than normative mean: + p < .05
Significant correlation: * p < .05, ** p < .01, *** p < .001
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Range
5-50
67-109
0.60-1.57
1-13
0.57-1.57
0.40-1.27
0.55-1.28
70-132
3-16
4-16

r
.836
-.534
-.256
-.206
-.315
-.118
-.464
-.530
-.600
-.341

p
<.001***
.007**
.227
.333
.133
.582
.023*
.008**
.002**
.103

Table 8.
Summary of SRS-2 Total Scores from Previous Studies
Research Study
Huijbregts & Sonneville, 2011
Walsh et al., 2012
Garg et al., 2013b
Adviento et al., 2013
Plasschaert et al., 2014

N (M/F)
30 (12/18)
66 (42/24)
109 (50/59)
66 (26/40)
82 (44/38)

Ages
6-17
4-48
4-16
2-45
5-17
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M (SD)
59.4 (23.4)
57.9 (14.2)
63.2 (35.4)
57.0 (16.0)
58.3 (32.5)

Levels of Difficulty
<60 61-75 >75
---60%
27%
13%
44%
27%
29%
57%
30%
13%
37%
30%
33%

Figure 1.
SRS-2 Levels of Difficulties
SRS-2 Levels of Difficulties
100%
90%
80%
70%
60%
50%
40%
30%
20%
10%
0%
Severe
Moderate
Mild
Normal

Awareness
0
5
4
15

Cognition
1
4
1
18

Comm
2
4
1
17

Motivation
0
4
3
17

RRB
0
3
4
17

SCI
0
6
1
17

Total
0
6
1
17

Figure 1. Bar chart depicting levels of difficulties reported by parents on the SRS-2 by each domain and index.
Comm = Communication; RRB = Restricted, Repetitive Behaviors; SCI = Social Communication & Interaction
Index; Total = SRS-2 Total Score.
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Figure 2.
Distribution of SCQ Total Scores
Distribution of SCQ Total Scores
10
9

Number of Participants

8
7
6
5
4
3
2
1

Raw
0
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15*
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34

0

SCQ Total Score
Figure 2. Line chart depicting distribution of SCQ Total Scores reported by parents. * Denotes the SCQ Total Score
cutoff score.
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Figure 3.
Distribution of ASI Total Scores
Distribution of ASI Total Scores
10
9

Number of Participants

8
7
6
5
4
3
2
1
0
Raw 6

8

10 12 14 16 18 20 22 24 26 28 30 32 34 36 38* 40 42 44 46 48 50

ASI Total Score
Figure 3. Line chart depicting distribution of ASI Total Scores reported by parents. * Denotes the ASI Total Score
cutoff.
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Figure 4.
Distribution of ADOS-2 Domain Scores

Number of Participants

Distribution of ADOS-2 Domain Scores
25
24
23
22
21
20
19
18
17
16
15
14
13
12
11
10
9
8
7
6
5
4
3
2
1
0

0

1

2

3

4

5

6

7*

8

9**

10

SA Domain

9

10

3

0

2

0

0

0

1

0

0

RRB Domain

21

3

1

0

0

0

0

0

0

0

0

Total Score

9

8

5

0

0

1

1

0

1

0

0

22

0

2

0

1

0

0

0

0

0

Severity Score

Figure 4. Multiline chart depicting distribution of ADOS-2 domain scores and severity scores. * Denotes Autism
Spectrum Disorder cutoff score; ** Denotes Autism cutoff score. SA = Social Affect; RRB = Restricted and
Repetitive Behavior.
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Appendix A
Collaborative Programs of Excellence in Autism (CPEA) Diagnosis
CPEA Diagnoses of Autism, Asperger Disorder, or ASD are determined hierarchically and
based upon scores from the ADI-R, ADOS, and the Best Estimate Clinical (BEC) diagnosis
made by the supervising clinicians; criteria for Asperger’s also include consideration of child
age, IQ, and language milestones. These criteria were established by the CPEA to ensure
standardized diagnostic classification across sites and adopted by the SSC under the same
rationale. The criteria used in the SSC were slightly modified from those described by Lainhart
et al. (2006):
1. For a CPEA diagnosis of “Autism” an individual must meet the following:
a. ADI-R classification of “Autism.” This is based on meeting published cut-offs on the
ADI-R diagnostic algorithm (LeCouteur et al., 2003) in the domains of Reciprocal Social
Interaction (SOC), Communication, Restricted, Repetitive & Stereotyped Patterns (RRB)
of Behaviors, and Age of Onset.
b. ADOS classification of “Autism” or “Autism Spectrum.” This is based on meeting
published cut-offs on the revised diagnostic algorithms for Modules 1-3 (Gotham et al.,
2009) and cut-offs on the originally published diagnostic algorithms for Module 4 (Lord
et al., 2000).
c. BEC Diagnosis of “Autism,” “Autism Spectrum” or “Asperger’s.”
2. For a CPEA diagnosis of “Asperger’s” an individual must not meet criteria for “Autism” and
must also meet the following:
a. Chronological age of 5 years or older
b. Verbal IQ of 80 or above
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c. Age of First Words (from the ADI-R) is 24 months or younger
d. Age of First Phrases (from the ADI-R) is 33 months or younger
e. ADI-R classification is not “Autism”
f. ADI-R SOC domain score is 10 or higher
g. ADI-R RRB domain score is 2 or higher
h. ADOS classification of “Autism” or “Autism Spectrum” or ADOS
Social+Communication Total (based on originally published algorithms) is 4 or higher
i. BEC Diagnosis of “Autism,” “Autism Spectrum” or “Asperger’s.”
3. For a CPEA diagnosis of “Autism Spectrum Disorder” an individual must not previous
criteria for “Autism” or “Asperger’s” and must also meet the following:
a. ADI-R classification of “Autism Spectrum.” This is based on CPEA criteria (Lainhart et
al., 2006; Risi et al., 2006), which requires one of the following:
i. Meeting cut-offs on the SOC and Communication domains
ii. Meeting cut-offs on either the SOC or Communication domain and score within 2
points of the cut-off on the other
iii. Score within 1 point on both the SOC and Communication domains.
b.

ADOS classification of “Autism Spectrum.” This is based on revised diagnostic
algorithms for Modules 1-3 and originally published diagnostic algorithms for Module 4.

c. BEC Diagnosis of “Autism,” “Autism Spectrum” or “Asperger’s.”
4. If none of the above criteria is met, the participant receives a CPEA diagnosis of
“Nonspectrum”.
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Appendix B
ASI Total Score Correlations to Related Variables
In order better understand what variables could help explain social difficulties reported
by parents of children with NF1, the relationship between the ASI Total Score and the variables
described above were investigated using Pearson product-moment correlation coefficients.
Preliminary analyses were performed to ensure no violation of the assumptions of normality,
linearity, and homoscedasticity. There were medium, negative correlations between ASI Total
Score and GCA (r = -.45, n = 25, p = .02), SECT (r = -.39, n = 25, p = .05), and MPLI (r = -.49,
n = 25, p = .01). Given the significant correlation found between the ASI Total score and GCA,
additional correlational analyses were conducted to examine if a specific domain score was
responsible for driving the correlation. Given the significant correlation between the ASI Total
score and MPLI, additional correlational analyses were investigated. Results highlighted a large,
negative correlation between the ASI Total score and MI (r = -.65, n = 25, p < .001). There was
no significant correlation between the ASI Total score and CS (r = -.21, n = 25, p = .32).
Measures/Subtests
SRS-2 Total Score
GCA
Identification Task
AA/RS Combined
One Back Task
Two Back Task
Cogstate SECT
Pragmatic Language
Making Inferences
Conversation Skills

Score
T-score
Standard
Accuracy
Scaled
Accuracy
Accuracy
Accuracy
Standard
Scaled
Scaled

M
55.76+
90.84+
1.31
8.16+
1.15
0.99
0.94
98.76
8.60+
10.92

SD
10.65
11.63
0.22
3.39
0.25
0.25
0.20
17.01
3.39
3.34

Significantly higher than normative mean: + p < .05
Significant correlation: * p < .05, ** p < .01
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Range
40-75
67-109
0.60-1.57
1-13
0.57-1.57
0.40-1.27
0.55-1.28
70-132
3-16
4-16

r
.836
-.450
-.233
-.092
-.266
-.126
-.391
-.485
-.645
-.208

p
<.001***
.024*
.263
.661
.199
.548
.054*
.014*
.001**
.318
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Cum Laude Graduation Honors / 2006
Deans List, University of Missouri-St. Louis / 2002 – 2006
University Scholarship / 2002 – 2006

TRAINING
Leadership Education in Neurodevelopmental and Related Disabilities
University of Wisconsin – Milwaukee / Milwaukee, Wisconsin / 2013 – 2014
Track: Psychology Fellow
The LEND program provides graduate level interdisciplinary training to improve the health and
quality of life for individuals with disabilities. Participation in leadership trainings, learning modules
focused on increasing knowledge of neurodevelopmental disabilities, interdisciplinary research
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teams, education, and advocacy of relevant public policy, and participation in a weekly,
interdisciplinary clinic specializing in the diagnosis of autism spectrum disorders.
Clinical and Research Reliability Certification: ADI-R and ADOS-2 (Modules 1 - 4)
University of Wisconsin – Milwaukee / Milwaukee, Wisconsin / 2013
Advanced training and completed research reliability certification in Autism Diagnostic Interview –
Revised (ADI-R) and Autism Diagnostic Observation Schedule – Second Edition (ADOS-2) for modules
1 – 4. Established at least 80% agreement on the ADOS-2 for both protocol and algorithm and at
least 90% agreement on the ADI-R for both protocol and algorithm on at least three consecutive
administrations.

CLINICAL EXPERIENCE
Doctoral Internship in Clinical Psychology
University of Chicago Medicine / Chicago, Illinois / 2016 – Present
Track: Pediatric Neuropsychology
Supervisors: Scott Hunter, Ph.D.; Megan Scott, Ph.D.; Matthew Young, Ph.D.; Tina Drossos, Ph.D.
Outpatient neuropsychological evaluation with children and adolescents with complex medical,
neurological, neurodevelopmental, and genetic disorders through the Pediatric Neuropsychology
Clinic and Neurodevelopmental Disorder Clinic. Outpatient diagnostic evaluation and intervention
with children and families with a variety of sleep disorders through the Pediatric Sleep Clinic.
Individual and family outpatient psychotherapy with community children, with and without medical
conditions, through the Child Psychology Clinic. Assessment and intervention for a variety of
psychological concerns related to medical illness/treatments as part of an inpatient,
multidisciplinary environment through the Pediatric Psychiatry Consultation & Liaison Service.
Consultation regarding cognitive, behavioral, and adaptive needs and brief outpatient
neuropsychology evaluations with children and adolescents seen through the Pediatric Neurology
Clinic.
Advanced Student Therapist: UWM Child Anxiety Clinic
University of Milwaukee - Wisconsin / Milwaukee, Wisconsin / 2014 – 2016
Supervisor: Bonnie Klein-Tasman, Ph.D.
Provided interventions with children and adolescents with Social Anxiety Disorder and Generalized
Anxiety Disorder as part of a community, no-fee clinic. Supervision in cognitive-behavioral and
family systems approaches.
Advanced LEND Trainee: WI LEND – Milwaukee Link ASD Diagnostic Clinic
University of Milwaukee - Wisconsin / Milwaukee, Wisconsin / 2013 – 2016
Supervisor: Bonnie Klein-Tasman, Ph.D.
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Administered, scored, and interpreted developmental testing and gold standard diagnostic
measures (ADOS-2; ADI-R) to young children referred for concerns of a possible autism spectrum
disorder as part of a community, no-fee clinic. Worked as part of an interdisciplinary team with
speech therapists, occupational therapists, and nurse practitioners to provide comprehensive
diagnostic evaluations.
Graduate Assistant: UWM Child Neuropsychology Clinic
University of Milwaukee - Wisconsin / Milwaukee, Wisconsin / 2010 – 2016
Supervisor: Bonnie Klein-Tasman, Ph.D.
Completed neuropsychological evaluations, report writing, and feedback for children and
adolescents with learning disabilities, ADHD, autism spectrum disorders, and other genetic and
neurodevelopmental disorders.
Teen & Young Adult Lead Therapist: Marquette University PEERS Project
Marquette University / Milwaukee, Wisconsin / 2013 – 2015
Supervisor: Amy Van Hecke, Ph.D.
Provided evidence-based, manualized, 14/16-week, relationship-development therapy for a group
of teens/young adults, with autism spectrum disorders utilizing the Program for the Education and
Enrichment of Relational Skills (PEERS) intervention program.
Advanced Practicum Student: Pediatric Neuropsychology Clinic
Medical College of Wisconsin / Milwaukee, Wisconsin / 2013 – 2015
Supervisor: Amy Heffelfinger, Ph.D., ABPP; Jennifer Koop, Ph.D., ABPP; Michelle Loman, Ph.D.
Provided neuropsychological evaluations, observation of parent-child interactions, report writing,
attending feedback for children and adolescents in a hospital outpatient setting. Experience in
working with children of all ages, including preschool and infant evaluations in the Preschool and
Infant Neuropsychological Testing clinic.
Project Assistant: UWM Adult Neuropsychology Learning Disabilities Clinic
University of Milwaukee - Wisconsin / Milwaukee, Wisconsin / 2012 – 2013
Supervisor: David Osmon, Ph.D., ABPP
Comprehensive neuropsychological evaluations and scoring for adults with learning disabilities,
ADHD, and a variety of mood disorders. Measures administered included intellectual functioning,
academic, executive functions, memory, effort, personality, learning styles, and career measures.
Student Therapist: UWM Tic Disorders Clinic
University of Milwaukee - Wisconsin / Milwaukee, Wisconsin / 2012 – 2013
Supervisor: Doug Woods, Ph.D.
Provided outpatient therapy for children and adolescents with concerns related to mood disorders,
behavioral difficulties, anxiety, and repetitive behavior disorders such as Obsessive Compulsive
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Disorder, tic disorders, and Trichotillomania. Interventions included behavioral activation, habit
reversal training, cognitive-behavioral therapy, and parent training.
Student Therapist: Pediatric Constipation and Incontinence Clinic
Children’s Hospital of Wisconsin / Milwaukee, Wisconsin / 2012 – 2013
Supervisor: W. Hobey Davies, Ph.D.; Alan Silverman, Ph.D.; Andrea Begotka, Ph.D.
Provided outpatient therapy with families and young children with encopresis and enuresis in an
outpatient hospital setting. Conducted initial evaluation and weekly treatment utilizing behavior and
family therapy techniques.
Clinical Psychology Practicum Student: UWM Psychology Clinic
University of Milwaukee - Wisconsin / Milwaukee, Wisconsin / 2010 – 2012
Supervisor: David Osmon, Ph.D., ABPP; Bonnie Klein-Tasman, Ph.D.; Han Joo Lee, Ph.D.
Provided diagnostic and psychoeducational assessments for college students and children referred
from the community. Participated in school Individualized Education Program meetings as part of
practicum experience.
Pediatric Neuropsychology Psychometrist: University of Chicago
Pediatric Neuropsychology Service & Pediatric Forensic Psychiatry Program
University of Chicago / Chicago, Illinois / 2008 – 2010
Supervisor: Scott Hunter, Ph.D.
Conducted neuropsychological assessments for children and adolescents with a wide range of
psychological and medical concerns. Assisted in pre- and post- brain surgery testing and WADA
testing for the pediatric epilepsy team. Scored and checked accuracy of test data; supervised testing
by trainees; attended weekly didactics focused on pediatric and adult neurological and
neuropsychological concerns.
Lead ABA Therapist: St. Louis Special School District
St. Louis Special School District / Chicago, Illinois / 2003 – 2006
Supervisor: Julie Snider, M.A.
Provided applied behavioral analysis (ABA) therapy with young children diagnosed with an autism
spectrum disorder. Collected detailed data on core curriculum. Managed team of therapists on
specific skill development and new procedures. Met and reported weekly with school personal on
progress and areas of concern.

PUBLICATIONS
McVey, A. J., Dolan, B. K., Willar, K. S., Pleiss, S., Karst, J. S., Casnar, C. L., Caiozzo, C., Vogt, E. M.,
Gordon, N. S., & Vaughan Van Hecke, A. (2016). A replication and extension of the PEERS® for Young
Adults intervention: Examining effects on social skills and social anxiety in young adults with autism
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spectrum disorder. Journal of Autism and Developmental Disabilities (46), 3739.
doi:10.1007/s10803-016-2911-5
Casnar, C. L. & Klein-Tasman, B. P. (2016). Parent and teacher perspectives on emerging executive
functioning in preschoolers with neurofibromatosis type 1: Comparison to unaffected children and
lab-based measures. Journal of Pediatric Psychology. doi: 10.1093/jpepsy/jsw042
Casnar, C. L., Janke, K., van der Fluit, F., Brei, N., & Klein-Tasman, B. P. (2014). Relations between fine
motor skill and parental reports of attention in young children with neurofibromatosis-1. Journal of
Experimental and Clinical Psychology, 36(9), 930-943.
Brei, N., Casnar, C. L., Schwarz, G. N. & Klein-Tasman, B. P. (2014). Language in young children with
neurofibromatosis-1: Relations to functional communication, attention, and social functioning.
Research in Developmental Disabilities, 35, 2495-2504.
Klein-Tasman, B. P., Janke, K. M., Luo, W., Casnar, C. L., Hunter, S. J., Tonsgard, J., Trapane, P., van der
Fluit, F. & Kais, L. A. (2013). Cognitive and psychosocial phenotype of young children with
neurofibromatosis-1. Journal of the International Neuropsychological Society, 20, 1-11.
Klein-Tasman, B. P., Colon, A. M., Brei, N., van der Fluit, F., Casnar, C. L., Janke, K. M., Basel, D., Siegel, D.
H. & Walker, J. A. (2013). Adaptive behavior in young children with neurofibromatosis type 1.
International Journal of Pediatrics, 2013, 7 pages.
Hunter, S. J. & Casnar, C. L. (2010). Juvenile Huntington’s Disorder. In B. Caplan, J. DeLuca, & J. S.
Kreutzer (Eds.), Encyclopedia of clinical neuropsychology. NY: Springer Science & Business Media,
LLC.

INTERNATIONAL / NATIONAL PRESENTATIONS
Casnar, C. L., Yund, B. D., Janke, K. M., & Klein-Tasman, B. P. (2016, February). Longitudinal Examination
of Fine Motor Skills in Children with Neurofibromatosis type 1. Oral paper presentation presented at
the 44th Annual Meeting of the International Neuropsychological Society: Boston, Massachusetts.
Casnar, C. L., Rivera, K., Helms, M. & Klein-Tasman, B. P. (2015, February). Parent and Teacher
Perspectives on BASC-II Content Scales in Young Children with NF1. Poster presented at the 43rd
Annual Meeting of the International Neuropsychological Society: Denver, Colorado.
McVey, A. J., Dolan, B., Schohl, K. A., Stevens, S., Karst, J. S., Carson, A. M., Casnar, C. L., Timmer-Murillo,
S., Vogt, E., Chesney, S. A., Reiter, K., Gordon, N., & Van Hecke, A. V. (2015, May). The Impact of the
PEERS® Intervention on Social Phobia in Young Adults with ASD. Poster presentation at the 2015
International Meeting for Autism Research (IMFAR), Salt Lake City, UT.
Jain, N., Ahamed, S., Stevens, S., Schohl, K. A., Dolan, B., McVey, A. J., Potts, S., Casnar, C. L., Caiozzo, C.,
Vogt, E. M., & Van Hecke, A. V. (2015, May). Physiological Monitoring during PEERS®: A "CultureFree" Method of Understanding Intervention Response. Panel presentation at the 2015 International
Meeting for Autism Research (IMFAR), Salt Lake City, UT.
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Brei, N. G., Casnar, C. L., van der Fluit, F., Mambwe, C., Waldron, S., Hunter, S. J., Tonsgard. J., & KleinTasman, B. P. (2014, February). Relations of Language Functioning to Attention, Functional
Communication and Social Skills in Young Children with NF1. Poster presented at the 42nd Annual
Meeting of the International Neuropsychological Society: Seattle, Washington.
Casnar, C. L., Schuett, M., Janke, K. M., Hunter, S. J., & Klein-Tasman, B. P. (2014, February). Parent
perspectives on executive functioning in preschoolers with NF1: comparison to typically developing
controls and teacher ratings. Poster presented at the 42nd Annual Meeting of the International
Neuropsychological Society: Seattle, Washington.
Casnar, C. L., Janke, K. M., van der Fluit, F., Brei, N. & Klein-Tasman, B. P. (2013, October). Relations
between fine motor skill and parental report of attention in young children with neurofibromatosis
type 1. Poster presented at the National Academy of Neuropsychology 33rd Annual Conference: San
Diego, CA.
Janke, K. M., Casnar, C. L., van der Fluit, F., Haberman, D. A., Brei, N. G., Hunter, S. J., & Klein-Tasman, B.
P. (2013, February). Concurrent relations between early neuropsychological and academic skills in
young children with NF1 and typically developing peers. Poster presented at the 41st Annual
Meeting of the International Neuropsychological Society: Waikoloa, Hawaii.
Klein-Tasman, B. P., Schuett, M., Kais, L. A., Hunter, S. H., Tonsgard, J., & Casnar, C. L. (2012, June).
Parent perspectives on executive functioning in preschoolers with NF1: Comparison to typically
developing controls and teacher ratings. Poster presented at the 2012 Neurofibromatosis
Conference: New Orleans, LA.
Casnar, C. L., Kais, L. A., van der Fluit, F., & Klein-Tasman, B. P. (2012, February). Fine Motor Abilities in
Young Children with Neurofibromatosis-1. Poster presented at the 40th Annual Meeting of the
International Neuropsychological Society: Montreal, Quebec.
Casnar, C. L., DiQuattro, M., Young, C. & Hunter, S. J. (2011, February). Verbal learning, Memory and
Discriminability in Children with Attention Deficit Hyperactivity Disorder (ADHD), Autism, and cooccurring ADHD and Autism. Future presentation to the 39th Annual Meeting of the International
Neuropsychology Society, Boston, MA.
Casnar, C. L. & Hunter, S. J. (2010, February). Utility of the BASC-2 and BRIEF in Discriminating Autism
Spectrum Disorder (ASD), Attention Deficit Hyperactivity Disorder (ADHD), and Comorbid
ASD/ADHD. Future presentation to the 38th Annual Meeting of the International Neuropsychology
Society, Acapulco, Mexico.
Thome, J., Hunter, S. J., Drossos, T., & Casnar, C. L. (2010, February). Open-Lip Schizencephaly:
Neurobehavioral Presentation of an 8-Year Old Boy. Presentation to the 38th Annual Meeting of the
International Neuropsychology Society, Acapulco, Mexico.
Hunter, S.J., Kohrman, M., Sinsioco, M., Casnar, C. L., & Ogden, P. (2010, February). Neurocognitive and
Behavioral Outcomes of Pediatric Epilepsy Surgery. Presentation to the 38th Annual Meeting of the
International Neuropsychology Society, Acapulco, Mexico.
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Sinsioco, C., Kohrman M., Hunter, S., Malzer, V., & Casnar, C. L. (2008, December). Neurocognitive
outcomes of pediatric patients after epilepsy surgery. Presentation to the 62nd Annual Meeting of
the American Epilepsy Society, Seattle, WA.

REGIONAL PRESENTATIONS
Rivera, K. M., Helms, M. I., Casnar, C. L., Brei, N. G., Schwarz, G. N., & Klein-Tasman, B. P. (2014, April).
Examination of BASC-II Content Scales in Young Children with Neurofibromatosis-1. Poster presented
at the UWM’s 6th annual Undergraduate Research Symposium: Milwaukee, WI.
Anglin, T., Basche, K., Casnar, C. L., Brei, N. G., Schwarz, G. N., & Klein-Tasman, B. P. (2014, April). Social
Skills of Young Children with NF1: Relations to Attention Problems and Cognitive Functioning. Poster
presented at UWM’s 6th annual Undergraduate Research Symposium: Milwaukee, WI.
Bennett, D. A., Janke, K. M., Casnar, C. L., & Brei, N. (2013, April). “Hot” and “Cool” Executive Functioning
in Children with Neurofibromatosis Type. Poster presented at the 27th National Conference on
Undergraduate Research: La Crosse, Wisconsin.
Colon, A. M., Walker, J. A., Brei, N. G., Casnar, C. L., van der Fluit, F. (2013, April). Adaptive Behavior in
Children with NF1 Considering the Role of Intellectual Functioning. Poster presented at the 27th
National Conference on Undergraduate Research: La Crosse, Wisconsin.
Solomon, M. S., Casnar, C. L., & Klein-Tasman, B. P. (2013, April). Lab-Based and Parent-Report
Assessment of Attention Difficulties in Children with Neurofibromatosis-1. Poster presented at
UWM’s 5th annual Undergraduate Research Symposium: Milwaukee, WI.
Schultz, C. S., Casnar, C. L., Brei, N. G., & Klein-Tasman, B. P. (2013, April). Attention in Young Children
with NF-1: Comparison to Unaffected Children. Poster presented at UWM’s 5th annual
Undergraduate Research Symposium: Milwaukee, WI.

RESEARCH EXPERIENCE
Doctoral Internship in Clinical Psychology
University of Chicago Medicine / Chicago, Illinois / 2016 – Present
Track: Pediatric Neuropsychology
Supervisor: Scott Hunter, Ph.D.
Neurocognitive and Psychiatric Functioning of Homeless Youth in Chicago and LA: A study aimed to
examine the family, academic, and interpersonal factors that may contribute to homelessness, as
well as, examine the relations among neuropsychological factors, psychosocial factors, and risky
behavior in homeless youth. Participants include English-speaking youth, aged 12-24, who lacked a
fixed, regular, and adequate nighttime residence in the Chicago or LA area. Role: Support Staff
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Graduate Assistant: UWM Child Neuropsychology Clinic
University of Milwaukee - Wisconsin / Milwaukee, Wisconsin / 2010 – 2016
Supervisor: Bonnie Klein-Tasman, Ph.D.
School-Aged Outcomes in Neurofibromatosis Type 1: Attention, Social, and Academic Functioning:
As a continuation of a longitudinal research study, this study aims to assess functioning at ages 9-13
to enable examination of preschool-age predictors of functioning in the school-age years.
Additionally, this study aims to characterize social difficulties in children with NF1 and identify
possible contributing factors to those social difficulties. Role: Co-Investigator
Response Inhibition Training for Children with Williams Syndrome: A pilot study aimed to examine
the effects of Response Inhibition Training for individuals with Williams syndrome on improving
impulsivity and general functioning levels. Responsibilities include administration of MINI and
neuropsychological measures at baseline, pre-intervention, post-intervention, and follow-up. Role:
Graduate Research Assistant
Early Indicators of Emotional, Cognitive, and Learning Difficulties in Neurofibromatosis Type 1: A
longitudinal study aimed at characterizing the cognitive and behavioral phenotype of young children
with Neurofibromatosis-1 as well as identifying risk factors of later learning or emotional problems
that allow to early intervention. Role: Graduate Research Assistant
Patience and Planning in Typically Developing Children: Examination of developing patience and
planning, cognitive functioning, and fine-motor skills in typically developing children; comparison
group for research about patience and planning in children with NF1 and Williams syndrome. Role:
Graduate Research Assistant
Pediatric Neuropsychology Psychometrist: University of Chicago
University of Chicago / Chicago, Illinois / 2008 – 2010
Supervisor: Scott Hunter, Ph.D.
Neurofibromatosis Type 1 (NF1) Clinical Trials Consortium: Phase II Study: A prospective
randomized placebo-controlled study of Lovastatin to improve neurocognitive outcome in
children between 10 and 17 years of age with NF1 and learning disabilities. Aim of study was to
determine whether Lovastatin significantly improves visual spatial learning and/or sustained
attention in children, ages 10 to 16, with NF1. Explored effect of Lovastatin on executive function,
behavior and quality of life. Role: Support Staff
Pediatric HIV/AIDS Cohort Study (PHACS): Adolescent Master Protocol (AMP). Examined cognitive,
behavioral, and risk factors in adolescents prenatally exposed to HIV-infected mothers. Study looked
at adolescents who are HIV-uninfected and those who are HIV-infected and taking ART. Study also
explored medical adherence in those children taking ART. Role: Support Staff
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Pediatric HIV/AIDS Cohort Study (PHACS): SMARTT (PH100) Protocol. Research investigates
potential toxicities and long term effects among HIV-uninfected children born to mothers with HIV
infection, with or without exposure to ART in utero and/or in the child’s first 2 months. Assessments
conducted on children (starting at 1 year old) and their caregiver. Role: Support Staff
Children’s Oncology Group Protocol ACNS0232: Radiotherapy alone vs. chemotherapy followed by
response-based radiotherapy for newly diagnosed primary CNS Germinoma: A phase-III group
wide study. Study compared survival, patterns of recurrence, health-related quality of life and
neuropsychological function in a prospective, randomized clinical trial of conventional radiotherapy
versus pre-radiotherapy chemotherapy followed by response-based reduced radiotherapy in
patients diagnosed with CNS Germinoma, between the ages of 3 and 25. Role: Support Staff
Children’s Oncology Group Protocol ALTE07C1: Neuropsychological, social, emotional, and
behavioral outcomes in children with cancer. Research aimed to streamline administration of
neuropsychological and behavioral test to patients with cancer. A streamlined, efficient battery will
help monitor the late effects in patients being treated for cancer. Neuropsychological batteries
designed for children as young as 2 years old to adults. Role: Support Staff
Neurological and behavioral change in the pediatric epilepsies. Study focused on examining
neuropsychological and behavioral changes in patients with intractable epilepsy, post resection
surgery. Patients assessed between 6 and 1 month pre-surgery and then again 6 months post
surgery. Role: Support Staff
Research Assistant: Human Behavior and Pharmacological Laboratory
University of Chicago / Chicago, Illinois / 2007 – 2008
Supervisor: Harriet de Wit, Ph.D.
Conducted clinical interviews, EKG, and administered questionnaires during participant screening
process. Managed all aspects of participant recruitment such as advertisement, screening and
tracking.
Research Assistant: Memory and Development Laboratory
Washington University / St. Louis, Missouri / 2006 – 2007
Supervisor: Pascal Boyer, Ph.D.
Assisted in recording and analyzing data and developed and submitted required documents for
Institutional Review Board process. Conducted interviews with child participants and administered
research measures in study protocol. Research studies conducted in natural and lab settings with
adults and children.
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SUPERVISION EXPERIENCE
Doctoral Internship in Clinical Psychology
University of Chicago Medicine / Chicago, Illinois / 2016 – Present
Track: Pediatric Neuropsychology
Supervisor: Scott Hunter, Ph.D.
Supervised advanced graduate students in research and clinical experiences. Provided clinical
research supervision with pediatric neuropsychology externs with administration, scoring,
interpretation, and report writing as part of Homeless Youth Study. Provided clinical supervision in
Neurodevelopmental Disorders Clinic. Supervised advanced graduate students and psychiatry fellow
in the administration of neuropsychological evaluations, including administration and scoring on the
ADOS-2 (all modules).
Advanced Student Therapist: UWM Child Anxiety Clinic
University of Milwaukee - Wisconsin / Milwaukee, Wisconsin / 2014 – 2016
Supervisor: Bonnie Klein-Tasman, Ph.D.
Supervised third-year graduate students and provided individual cognitive-behavioral therapy to
community clients in a low-cost clinic that specialized in treating children with anxiety disorders.
Clinical Psychology Practicum Supervisor: UWM Psychology Clinic
University of Milwaukee - Wisconsin / Milwaukee, Wisconsin / 2013 – 2014
Supervisor: Bonnie Klein-Tasman, Ph.D.; Han Joo Lee, Ph.D.
Supervised second-year graduate students in administration of neuropsychological and clinical
assessments with patients from the child neuropsychology and general psychology clinic. Provided
individual student feedback and supervision following assessment sessions. Facilitated course
meetings and participation in weekly group supervision of supervision to review progress of the
students and approaches to supervision.
Clinical Psychology Practicum Supervisor: UWM Psychology Clinic
University of Milwaukee - Wisconsin / Milwaukee, Wisconsin / 2011 – 2012
Supervisor: Bonnie Klein-Tasman, Ph.D.; Han Joo Lee, Ph.D.
Supervised first-year graduate students completing psychodiagnostic and neuropsychological
assessments, including nonspecific/general factors in client interactions. Participation in weekly
group supervision of supervision to review progress of the students and approaches to supervision.

TEACHING EXPERIENCE
Associate Lecturer: Online Child Psychology
University of Wisconsin - Milwaukee, Milwaukee, Wisconsin
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Spring 2015

Teaching Assistant: Online Child Psychology
University of Wisconsin - Milwaukee, Milwaukee, Wisconsin

Spring 2011

Teaching Assistant: Child Psychology
University of Wisconsin - Milwaukee, Milwaukee, Wisconsin

Fall 2010

PROFESSIONAL SERVICE
Member of American Psychological Association
Member of International Neuropsychology Society
Member of National Academy of Neuropsychology
Division 40 Association of Neuropsychology Students in Training
Health Psychology Graduate Student Club: UWM Chapter Secretary
Clinical Training Committee Student Representative
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2012 – Present
2012 – Present
2012 – Present
2012 – Present
2012 – 2016
2010 – 2013

